Intervening on the Side Effects of Hormone-Dependent Cancer Treatment: The Role of Strength Training
Identifieur interne : 004A95 ( Pmc/Corpus ); précédent : 004A94; suivant : 004A96Intervening on the Side Effects of Hormone-Dependent Cancer Treatment: The Role of Strength Training
Auteurs : Erik D. Hanson ; Ben F. HurleySource :
- Journal of Aging Research [ 2090-2204 ] ; 2011.
Abstract
While prostate and breast cancers are both highly prevalent and treatable using hormone suppression therapy, a constellation of side effects ensue, which mimic typical aging effects but at an accelerated pace. Because strength training is considered to be an intervention of choice for addressing the musculoskeletal and metabolic consequences of normal aging in older adults, it may be an effective intervention to attenuate or reverse the side effects of hormone-dependent cancer treatment. This paper provides an overview of the independent effects of strength training on common musculoskeletal and metabolic side effects of hormone-dependent therapy used for prostate and breast cancers. Strength training appears to be an effective complementary therapy for some of the adverse effects of prostate and breast treatment. Future research needs to address potential mechanisms to explain recent findings and to explore the role of strength training in addressing specific risk factors resulting from cancer treatment.
Url:
DOI: 10.4061/2011/903291
PubMed: 21318049
PubMed Central: 3034975
Links to Exploration step
PMC:3034975Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Intervening on the Side Effects of Hormone-Dependent Cancer Treatment: The Role of Strength Training</title><author><name sortKey="Hanson, Erik D" sort="Hanson, Erik D" uniqKey="Hanson E" first="Erik D." last="Hanson">Erik D. Hanson</name><affiliation><nlm:aff id="I1">Department of Kinesiology, School of Public Health, University of Maryland, College Park, MD 20742, USA</nlm:aff></affiliation></author><author><name sortKey="Hurley, Ben F" sort="Hurley, Ben F" uniqKey="Hurley B" first="Ben F." last="Hurley">Ben F. Hurley</name><affiliation><nlm:aff id="I1">Department of Kinesiology, School of Public Health, University of Maryland, College Park, MD 20742, USA</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">21318049</idno><idno type="pmc">3034975</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034975</idno><idno type="RBID">PMC:3034975</idno><idno type="doi">10.4061/2011/903291</idno><date when="2011">2011</date><idno type="wicri:Area/Pmc/Corpus">004A95</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">004A95</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Intervening on the Side Effects of Hormone-Dependent Cancer Treatment: The Role of Strength Training</title><author><name sortKey="Hanson, Erik D" sort="Hanson, Erik D" uniqKey="Hanson E" first="Erik D." last="Hanson">Erik D. Hanson</name><affiliation><nlm:aff id="I1">Department of Kinesiology, School of Public Health, University of Maryland, College Park, MD 20742, USA</nlm:aff></affiliation></author><author><name sortKey="Hurley, Ben F" sort="Hurley, Ben F" uniqKey="Hurley B" first="Ben F." last="Hurley">Ben F. Hurley</name><affiliation><nlm:aff id="I1">Department of Kinesiology, School of Public Health, University of Maryland, College Park, MD 20742, USA</nlm:aff></affiliation></author></analytic><series><title level="j">Journal of Aging Research</title><idno type="ISSN">2090-2204</idno><idno type="eISSN">2090-2212</idno><imprint><date when="2011">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>While prostate and breast cancers are both highly prevalent and treatable using hormone suppression therapy, a constellation of side effects ensue, which mimic typical aging effects but at an accelerated pace. Because strength training is considered to be an intervention of choice for addressing the musculoskeletal and metabolic consequences of normal aging in older adults, it may be an effective intervention to attenuate or reverse the side effects of hormone-dependent cancer treatment. This paper provides an overview of the independent effects of strength training on common musculoskeletal and metabolic side effects of hormone-dependent therapy used for prostate and breast cancers. Strength training appears to be an effective complementary therapy for some of the adverse effects of prostate and breast treatment. Future research needs to address potential mechanisms to explain recent findings and to explore the role of strength training in addressing specific risk factors resulting from cancer treatment.</p></div></front><back><div1 type="bibliography"><listBibl><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Jemal, A" uniqKey="Jemal A">A Jemal</name></author><author><name sortKey="Siegel, R" uniqKey="Siegel R">R Siegel</name></author><author><name sortKey="Ward, E" uniqKey="Ward E">E Ward</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Yancik, R" uniqKey="Yancik R">R Yancik</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lucia, A" uniqKey="Lucia A">A Lucía</name></author><author><name sortKey="Earnest, C" uniqKey="Earnest C">C Earnest</name></author><author><name sortKey="Perez, M" uniqKey="Perez M">M Pérez</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Dimeo, Fc" uniqKey="Dimeo F">FC Dimeo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bylow, K" uniqKey="Bylow K">K Bylow</name></author><author><name sortKey="Mohile, Sg" uniqKey="Mohile S">SG Mohile</name></author><author><name sortKey="Stadler, Wm" uniqKey="Stadler W">WM Stadler</name></author><author><name sortKey="Dale, W" uniqKey="Dale W">W Dale</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hurley, Bf" uniqKey="Hurley B">BF Hurley</name></author><author><name sortKey="Roth, Sm" uniqKey="Roth S">SM Roth</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Johnston, Apw" uniqKey="Johnston A">APW Johnston</name></author><author><name sortKey="De Lisio, M" uniqKey="De Lisio M">M De Lisio</name></author><author><name sortKey="Parise, G" uniqKey="Parise G">G Parise</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Schmitz, Kh" uniqKey="Schmitz K">KH Schmitz</name></author><author><name sortKey="Cappola, Ar" uniqKey="Cappola A">AR Cappola</name></author><author><name sortKey="Stricker, Ct" uniqKey="Stricker C">CT Stricker</name></author><author><name sortKey="Sweeney, C" uniqKey="Sweeney C">C Sweeney</name></author><author><name sortKey="Norman, Sa" uniqKey="Norman S">SA Norman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hurley, Bf" uniqKey="Hurley B">BF Hurley</name></author><author><name sortKey="Hanson, Ed" uniqKey="Hanson E">ED Hanson</name></author><author><name sortKey="Sheaff, Ak" uniqKey="Sheaff A">AK Sheaff</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Williams, Mb" uniqKey="Williams M">MB Williams</name></author><author><name sortKey="Hernandez, J" uniqKey="Hernandez J">J Hernandez</name></author><author><name sortKey="Thompson, I" uniqKey="Thompson I">I Thompson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ryan, Pd" uniqKey="Ryan P">PD Ryan</name></author><author><name sortKey="Goss, Pe" uniqKey="Goss P">PE Goss</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Saarto, T" uniqKey="Saarto T">T Saarto</name></author><author><name sortKey="Blomqvist, C" uniqKey="Blomqvist C">C Blomqvist</name></author><author><name sortKey="V Lim Ki, M" uniqKey="V Lim Ki M">M Välimäki</name></author><author><name sortKey="M Kel, P" uniqKey="M Kel P">P Mäkelä</name></author><author><name sortKey="Sarna, S" uniqKey="Sarna S">S Sarna</name></author><author><name sortKey="Elomaa, I" uniqKey="Elomaa I">I Elomaa</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Shapiro, Cl" uniqKey="Shapiro C">CL Shapiro</name></author><author><name sortKey="Manola, J" uniqKey="Manola J">J Manola</name></author><author><name sortKey="Leboff, M" uniqKey="Leboff M">M Leboff</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Osborne, Ck" uniqKey="Osborne C">CK Osborne</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Boxer, Rs" uniqKey="Boxer R">RS Boxer</name></author><author><name sortKey="Kenny, Am" uniqKey="Kenny A">AM Kenny</name></author><author><name sortKey="Dowsett, R" uniqKey="Dowsett R">R Dowsett</name></author><author><name sortKey="Taxel, P" uniqKey="Taxel P">P Taxel</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Galvao, Da" uniqKey="Galvao D">DA Galvão</name></author><author><name sortKey="Spry, Na" uniqKey="Spry N">NA Spry</name></author><author><name sortKey="Taaffe, Dr" uniqKey="Taaffe D">DR Taaffe</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Levy, Me" uniqKey="Levy M">ME Levy</name></author><author><name sortKey="Perera, S" uniqKey="Perera S">S Perera</name></author><author><name sortKey="Van Londen, Gj" uniqKey="Van Londen G">GJ van Londen</name></author><author><name sortKey="Nelson, Jb" uniqKey="Nelson J">JB Nelson</name></author><author><name sortKey="Clay, Ca" uniqKey="Clay C">CA Clay</name></author><author><name sortKey="Greenspan, Sl" uniqKey="Greenspan S">SL Greenspan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Smith, Mr" uniqKey="Smith M">MR Smith</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Smith, Mr" uniqKey="Smith M">MR Smith</name></author><author><name sortKey="Finkelstein, Js" uniqKey="Finkelstein J">JS Finkelstein</name></author><author><name sortKey="Mcgovern, Fj" uniqKey="Mcgovern F">FJ McGovern</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Basaria, S" uniqKey="Basaria S">S Basaria</name></author><author><name sortKey="Lieb, J" uniqKey="Lieb J">J Lieb</name></author><author><name sortKey="Tang, Am" uniqKey="Tang A">AM Tang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Galvao, Da" uniqKey="Galvao D">DA Galvão</name></author><author><name sortKey="Taaffe, Dr" uniqKey="Taaffe D">DR Taaffe</name></author><author><name sortKey="Spry, N" uniqKey="Spry N">N Spry</name></author><author><name sortKey="Joseph, D" uniqKey="Joseph D">D Joseph</name></author><author><name sortKey="Turner, D" uniqKey="Turner D">D Turner</name></author><author><name sortKey="Newton, Ru" uniqKey="Newton R">RU Newton</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Coleman, Re" uniqKey="Coleman R">RE Coleman</name></author><author><name sortKey="Banks, Lm" uniqKey="Banks L">LM Banks</name></author><author><name sortKey="Girgis, Si" uniqKey="Girgis S">SI Girgis</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Eastell, R" uniqKey="Eastell R">R Eastell</name></author><author><name sortKey="Adams, Je" uniqKey="Adams J">JE Adams</name></author><author><name sortKey="Coleman, Re" uniqKey="Coleman R">RE Coleman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Eastell, R" uniqKey="Eastell R">R Eastell</name></author><author><name sortKey="Hannon, Ra" uniqKey="Hannon R">RA Hannon</name></author><author><name sortKey="Cuzick, J" uniqKey="Cuzick J">J Cuzick</name></author><author><name sortKey="Dowsett, M" uniqKey="Dowsett M">M Dowsett</name></author><author><name sortKey="Clack, G" uniqKey="Clack G">G Clack</name></author><author><name sortKey="Adams, Je" uniqKey="Adams J">JE Adams</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hadji, P" uniqKey="Hadji P">P Hadji</name></author><author><name sortKey="Body, Jj" uniqKey="Body J">JJ Body</name></author><author><name sortKey="Aapro, Ms" uniqKey="Aapro M">MS Aapro</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Smith, Mr" uniqKey="Smith M">MR Smith</name></author><author><name sortKey="Lee, Wc" uniqKey="Lee W">WC Lee</name></author><author><name sortKey="Brandman, J" uniqKey="Brandman J">J Brandman</name></author><author><name sortKey="Wang, Q" uniqKey="Wang Q">Q Wang</name></author><author><name sortKey="Botteman, M" uniqKey="Botteman M">M Botteman</name></author><author><name sortKey="Pashos, Cl" uniqKey="Pashos C">CL Pashos</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Demark Wahnefried, W" uniqKey="Demark Wahnefried W">W Demark-Wahnefried</name></author><author><name sortKey="Peterson, Bl" uniqKey="Peterson B">BL Peterson</name></author><author><name sortKey="Winer, Ep" uniqKey="Winer E">EP Winer</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Irwin, Ml" uniqKey="Irwin M">ML Irwin</name></author><author><name sortKey="Mctiernan, A" uniqKey="Mctiernan A">A McTiernan</name></author><author><name sortKey="Baumgartner, Rn" uniqKey="Baumgartner R">RN Baumgartner</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Basaria, S" uniqKey="Basaria S">S Basaria</name></author><author><name sortKey="Muller, Dc" uniqKey="Muller D">DC Muller</name></author><author><name sortKey="Carducci, Ma" uniqKey="Carducci M">MA Carducci</name></author><author><name sortKey="Egan, J" uniqKey="Egan J">J Egan</name></author><author><name sortKey="Dobs, As" uniqKey="Dobs A">AS Dobs</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Johansson, H" uniqKey="Johansson H">H Johansson</name></author><author><name sortKey="Gandini, S" uniqKey="Gandini S">S Gandini</name></author><author><name sortKey="Guerrieri Gonzaga, A" uniqKey="Guerrieri Gonzaga A">A Guerrieri-Gonzaga</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Smith, Mr" uniqKey="Smith M">MR Smith</name></author><author><name sortKey="Lee, H" uniqKey="Lee H">H Lee</name></author><author><name sortKey="Nathan, Dm" uniqKey="Nathan D">DM Nathan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Thomson, Ca" uniqKey="Thomson C">CA Thomson</name></author><author><name sortKey="Thompson, Pa" uniqKey="Thompson P">PA Thompson</name></author><author><name sortKey="Wright Bea, J" uniqKey="Wright Bea J">J Wright-Bea</name></author><author><name sortKey="Nardi, E" uniqKey="Nardi E">E Nardi</name></author><author><name sortKey="Frey, Gr" uniqKey="Frey G">GR Frey</name></author><author><name sortKey="Stopeck, A" uniqKey="Stopeck A">A Stopeck</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Joly, F" uniqKey="Joly F">F Joly</name></author><author><name sortKey="Alibhai, Smh" uniqKey="Alibhai S">SMH Alibhai</name></author><author><name sortKey="Galica, J" uniqKey="Galica J">J Galica</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kyrdalen, Ae" uniqKey="Kyrdalen A">AE Kyrdalen</name></author><author><name sortKey="Dahl, Aa" uniqKey="Dahl A">AA Dahl</name></author><author><name sortKey="Hernes, E" uniqKey="Hernes E">E Hernes</name></author><author><name sortKey="Hem, E" uniqKey="Hem E">E Hem</name></author><author><name sortKey="Foss, Sd" uniqKey="Foss S">SD Fosså</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Milne, Hm" uniqKey="Milne H">HM Milne</name></author><author><name sortKey="Wallman, Ke" uniqKey="Wallman K">KE Wallman</name></author><author><name sortKey="Gordon, S" uniqKey="Gordon S">S Gordon</name></author><author><name sortKey="Courneya, Ks" uniqKey="Courneya K">KS Courneya</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Clay, Ca" uniqKey="Clay C">CA Clay</name></author><author><name sortKey="Perera, S" uniqKey="Perera S">S Perera</name></author><author><name sortKey="Wagner, Jm" uniqKey="Wagner J">JM Wagner</name></author><author><name sortKey="Miller, Me" uniqKey="Miller M">ME Miller</name></author><author><name sortKey="Nelson, Jb" uniqKey="Nelson J">JB Nelson</name></author><author><name sortKey="Greenspan, Sl" uniqKey="Greenspan S">SL Greenspan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nesvold, Il" uniqKey="Nesvold I">IL Nesvold</name></author><author><name sortKey="Foss, Sd" uniqKey="Foss S">SD Foss</name></author><author><name sortKey="Holm, I" uniqKey="Holm I">I Holm</name></author><author><name sortKey="Naume, B" uniqKey="Naume B">B Naume</name></author><author><name sortKey="Dahl, Aa" uniqKey="Dahl A">AA Dahl</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rietman, Js" uniqKey="Rietman J">JS Rietman</name></author><author><name sortKey="Dijkstra, Pu" uniqKey="Dijkstra P">PU Dijkstra</name></author><author><name sortKey="Hoekstra, Hj" uniqKey="Hoekstra H">HJ Hoekstra</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Dacal, K" uniqKey="Dacal K">K Dacal</name></author><author><name sortKey="Sereika, Sm" uniqKey="Sereika S">SM Sereika</name></author><author><name sortKey="Greenspan, Sl" uniqKey="Greenspan S">SL Greenspan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ohira, T" uniqKey="Ohira T">T Ohira</name></author><author><name sortKey="Schmitz, Kh" uniqKey="Schmitz K">KH Schmitz</name></author><author><name sortKey="Ahmed, Rl" uniqKey="Ahmed R">RL Ahmed</name></author><author><name sortKey="Yee, D" uniqKey="Yee D">D Yee</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Delmonico, Mj" uniqKey="Delmonico M">MJ Delmonico</name></author><author><name sortKey="Kostek, Mc" uniqKey="Kostek M">MC Kostek</name></author><author><name sortKey="Doldo, Na" uniqKey="Doldo N">NA Doldo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hurley, Bf" uniqKey="Hurley B">BF Hurley</name></author><author><name sortKey="Redmond, Ra" uniqKey="Redmond R">RA Redmond</name></author><author><name sortKey="Pratley, Re" uniqKey="Pratley R">RE Pratley</name></author><author><name sortKey="Treuth, Ms" uniqKey="Treuth M">MS Treuth</name></author><author><name sortKey="Rogers, Ma" uniqKey="Rogers M">MA Rogers</name></author><author><name sortKey="Goldberg, Ap" uniqKey="Goldberg A">AP Goldberg</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lemmer, Jt" uniqKey="Lemmer J">JT Lemmer</name></author><author><name sortKey="Hurlbut, De" uniqKey="Hurlbut D">DE Hurlbut</name></author><author><name sortKey="Martel, Gf" uniqKey="Martel G">GF Martel</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Fielding, Ra" uniqKey="Fielding R">RA Fielding</name></author><author><name sortKey="Lebrasseur, Nk" uniqKey="Lebrasseur N">NK LeBrasseur</name></author><author><name sortKey="Cuoco, A" uniqKey="Cuoco A">A Cuoco</name></author><author><name sortKey="Bean, J" uniqKey="Bean J">J Bean</name></author><author><name sortKey="Mizer, K" uniqKey="Mizer K">K Mizer</name></author><author><name sortKey="Fiatarone Singh, Ma" uniqKey="Fiatarone Singh M">MA Fiatarone Singh</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ryan, As" uniqKey="Ryan A">AS Ryan</name></author><author><name sortKey="Ivey, Fm" uniqKey="Ivey F">FM Ivey</name></author><author><name sortKey="Hurlbut, De" uniqKey="Hurlbut D">DE Hurlbut</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sigal, Rj" uniqKey="Sigal R">RJ Sigal</name></author><author><name sortKey="Kenny, Gp" uniqKey="Kenny G">GP Kenny</name></author><author><name sortKey="Boule, Ng" uniqKey="Boule N">NG Boulé</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Smutok, Ma" uniqKey="Smutok M">MA Smutok</name></author><author><name sortKey="Reece, C" uniqKey="Reece C">C Reece</name></author><author><name sortKey="Kohhinos, Pf" uniqKey="Kohhinos P">PF Kohhinos</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Treuth, Ms" uniqKey="Treuth M">MS Treuth</name></author><author><name sortKey="Ryan, As" uniqKey="Ryan A">AS Ryan</name></author><author><name sortKey="Pratley, Re" uniqKey="Pratley R">RE Pratley</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Henwood, Tr" uniqKey="Henwood T">TR Henwood</name></author><author><name sortKey="Taaffe, Dr" uniqKey="Taaffe D">DR Taaffe</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Vincent, Kr" uniqKey="Vincent K">KR Vincent</name></author><author><name sortKey="Braith, Rw" uniqKey="Braith R">RW Braith</name></author><author><name sortKey="Feldman, Ra" uniqKey="Feldman R">RA Feldman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kirk, Ep" uniqKey="Kirk E">EP Kirk</name></author><author><name sortKey="Donnelly, Je" uniqKey="Donnelly J">JE Donnelly</name></author><author><name sortKey="Smith, Bk" uniqKey="Smith B">BK Smith</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lemmer, Jt" uniqKey="Lemmer J">JT Lemmer</name></author><author><name sortKey="Ivey, Fm" uniqKey="Ivey F">FM Ivey</name></author><author><name sortKey="Ryan, As" uniqKey="Ryan A">AS Ryan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ruiz, Jr" uniqKey="Ruiz J">JR Ruiz</name></author><author><name sortKey="Sui, X" uniqKey="Sui X">X Sui</name></author><author><name sortKey="Lobelo, F" uniqKey="Lobelo F">F Lobelo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Freedman, Rj" uniqKey="Freedman R">RJ Freedman</name></author><author><name sortKey="Aziz, N" uniqKey="Aziz N">N Aziz</name></author><author><name sortKey="Albanes, D" uniqKey="Albanes D">D Albanes</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Battaglini, C" uniqKey="Battaglini C">C Battaglini</name></author><author><name sortKey="Bottaro, M" uniqKey="Bottaro M">M Bottaro</name></author><author><name sortKey="Dennehy, C" uniqKey="Dennehy C">C Dennehy</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Courneya, Ks" uniqKey="Courneya K">KS Courneya</name></author><author><name sortKey="Segal, Rj" uniqKey="Segal R">RJ Segal</name></author><author><name sortKey="Mackey, Jr" uniqKey="Mackey J">JR Mackey</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Schwartz, Al" uniqKey="Schwartz A">AL Schwartz</name></author><author><name sortKey="Winters Stone, K" uniqKey="Winters Stone K">K Winters-Stone</name></author><author><name sortKey="Gallucci, B" uniqKey="Gallucci B">B Gallucci</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bhasin, S" uniqKey="Bhasin S">S Bhasin</name></author><author><name sortKey="Woodhouse, L" uniqKey="Woodhouse L">L Woodhouse</name></author><author><name sortKey="Storer, Tw" uniqKey="Storer T">TW Storer</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Segal, Rj" uniqKey="Segal R">RJ Segal</name></author><author><name sortKey="Reid, Rd" uniqKey="Reid R">RD Reid</name></author><author><name sortKey="Courneya, Ks" uniqKey="Courneya K">KS Courneya</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Segal, Rj" uniqKey="Segal R">RJ Segal</name></author><author><name sortKey="Reid, Rd" uniqKey="Reid R">RD Reid</name></author><author><name sortKey="Courneya, Ks" uniqKey="Courneya K">KS Courneya</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Galvao, Da" uniqKey="Galvao D">DA Galvão</name></author><author><name sortKey="Nosaka, K" uniqKey="Nosaka K">K Nosaka</name></author><author><name sortKey="Taaffe, Dr" uniqKey="Taaffe D">DR Taaffe</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hansen, Pa" uniqKey="Hansen P">PA Hansen</name></author><author><name sortKey="Dechet, Cb" uniqKey="Dechet C">CB Dechet</name></author><author><name sortKey="Porucznik, Ca" uniqKey="Porucznik C">CA Porucznik</name></author><author><name sortKey="Lastayo, Pc" uniqKey="Lastayo P">PC LaStayo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ahmed, Rl" uniqKey="Ahmed R">RL Ahmed</name></author><author><name sortKey="Thomas, W" uniqKey="Thomas W">W Thomas</name></author><author><name sortKey="Yee, D" uniqKey="Yee D">D Yee</name></author><author><name sortKey="Schmitz, Kh" uniqKey="Schmitz K">KH Schmitz</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Herman, S" uniqKey="Herman S">S Herman</name></author><author><name sortKey="Kiely, Dk" uniqKey="Kiely D">DK Kiely</name></author><author><name sortKey="Leveille, S" uniqKey="Leveille S">S Leveille</name></author><author><name sortKey="O Eill, E" uniqKey="O Eill E">E O’Neill</name></author><author><name sortKey="Cyberey, S" uniqKey="Cyberey S">S Cyberey</name></author><author><name sortKey="Bean, Jf" uniqKey="Bean J">JF Bean</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bean, Jf" uniqKey="Bean J">JF Bean</name></author><author><name sortKey="Kiely, Dk" uniqKey="Kiely D">DK Kiely</name></author><author><name sortKey="Herman, S" uniqKey="Herman S">S Herman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bean, Jf" uniqKey="Bean J">JF Bean</name></author><author><name sortKey="Leveille, Sg" uniqKey="Leveille S">SG Leveille</name></author><author><name sortKey="Kiely, Dk" uniqKey="Kiely D">DK Kiely</name></author><author><name sortKey="Bandinelli, S" uniqKey="Bandinelli S">S Bandinelli</name></author><author><name sortKey="Guralnik, Jm" uniqKey="Guralnik J">JM Guralnik</name></author><author><name sortKey="Ferrucci, L" uniqKey="Ferrucci L">L Ferrucci</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Metter, Ej" uniqKey="Metter E">EJ Metter</name></author><author><name sortKey="Conwit, R" uniqKey="Conwit R">R Conwit</name></author><author><name sortKey="Tobin, J" uniqKey="Tobin J">J Tobin</name></author><author><name sortKey="Fozard, Jl" uniqKey="Fozard J">JL Fozard</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jozsi, Ac" uniqKey="Jozsi A">AC Jozsi</name></author><author><name sortKey="Campbell, Ww" uniqKey="Campbell W">WW Campbell</name></author><author><name sortKey="Joseph, L" uniqKey="Joseph L">L Joseph</name></author><author><name sortKey="Davey, Sl" uniqKey="Davey S">SL Davey</name></author><author><name sortKey="Evans, Wj" uniqKey="Evans W">WJ Evans</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="L Nning, Pe" uniqKey="L Nning P">PE Lønning</name></author><author><name sortKey="Geisler, J" uniqKey="Geisler J">J Geisler</name></author><author><name sortKey="Krag, Le" uniqKey="Krag L">LE Krag</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Reid, Dm" uniqKey="Reid D">DM Reid</name></author><author><name sortKey="Doughty, J" uniqKey="Doughty J">J Doughty</name></author><author><name sortKey="Eastell, R" uniqKey="Eastell R">R Eastell</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Newton, Ru" uniqKey="Newton R">RU Newton</name></author><author><name sortKey="Taaffe, Dr" uniqKey="Taaffe D">DR Taaffe</name></author><author><name sortKey="Spry, N" uniqKey="Spry N">N Spry</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lohman, T" uniqKey="Lohman T">T Lohman</name></author><author><name sortKey="Going, S" uniqKey="Going S">S Going</name></author><author><name sortKey="Pamenter, R" uniqKey="Pamenter R">R Pamenter</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Menkes, A" uniqKey="Menkes A">A Menkes</name></author><author><name sortKey="Mazel, S" uniqKey="Mazel S">S Mazel</name></author><author><name sortKey="Redmond, Ra" uniqKey="Redmond R">RA Redmond</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nelson, Me" uniqKey="Nelson M">ME Nelson</name></author><author><name sortKey="Fiatarone, Ma" uniqKey="Fiatarone M">MA Fiatarone</name></author><author><name sortKey="Morganti, Cm" uniqKey="Morganti C">CM Morganti</name></author><author><name sortKey="Trice, I" uniqKey="Trice I">I Trice</name></author><author><name sortKey="Greenberg, Ra" uniqKey="Greenberg R">RA Greenberg</name></author><author><name sortKey="Evans, Wj" uniqKey="Evans W">WJ Evans</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Courtney, Ac" uniqKey="Courtney A">AC Courtney</name></author><author><name sortKey="Wachtel, Ef" uniqKey="Wachtel E">EF Wachtel</name></author><author><name sortKey="Myers, Er" uniqKey="Myers E">ER Myers</name></author><author><name sortKey="Hayes, Wc" uniqKey="Hayes W">WC Hayes</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Basaria, S" uniqKey="Basaria S">S Basaria</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Janssen, I" uniqKey="Janssen I">I Janssen</name></author><author><name sortKey="Ross, R" uniqKey="Ross R">R Ross</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Goodpaster, Bh" uniqKey="Goodpaster B">BH Goodpaster</name></author><author><name sortKey="Thaete, Fl" uniqKey="Thaete F">FL Thaete</name></author><author><name sortKey="Kelley, De" uniqKey="Kelley D">DE Kelley</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Goodpaster, Bh" uniqKey="Goodpaster B">BH Goodpaster</name></author><author><name sortKey="Carlson, Cl" uniqKey="Carlson C">CL Carlson</name></author><author><name sortKey="Visser, M" uniqKey="Visser M">M Visser</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Visser, M" uniqKey="Visser M">M Visser</name></author><author><name sortKey="Kritchevsky, Sb" uniqKey="Kritchevsky S">SB Kritchevsky</name></author><author><name sortKey="Goodpaster, Bh" uniqKey="Goodpaster B">BH Goodpaster</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Visser, M" uniqKey="Visser M">M Visser</name></author><author><name sortKey="Goodpaster, Bh" uniqKey="Goodpaster B">BH Goodpaster</name></author><author><name sortKey="Kritchevsky, Sb" uniqKey="Kritchevsky S">SB Kritchevsky</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ligibel, Ja" uniqKey="Ligibel J">JA Ligibel</name></author><author><name sortKey="Campbell, N" uniqKey="Campbell N">N Campbell</name></author><author><name sortKey="Partridge, A" uniqKey="Partridge A">A Partridge</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kintzel, Pe" uniqKey="Kintzel P">PE Kintzel</name></author><author><name sortKey="Chase, Sl" uniqKey="Chase S">SL Chase</name></author><author><name sortKey="Schultz, Lm" uniqKey="Schultz L">LM Schultz</name></author><author><name sortKey="O Ourke, Tj" uniqKey="O Ourke T">TJ O’Rourke</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Healy, La" uniqKey="Healy L">LA Healy</name></author><author><name sortKey="Ryan, Am" uniqKey="Ryan A">AM Ryan</name></author><author><name sortKey="Carroll, P" uniqKey="Carroll P">P Carroll</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Galvao, Da" uniqKey="Galvao D">DA Galvão</name></author><author><name sortKey="Taaffe, Dr" uniqKey="Taaffe D">DR Taaffe</name></author><author><name sortKey="Spry, N" uniqKey="Spry N">N Spry</name></author><author><name sortKey="Joseph, D" uniqKey="Joseph D">D Joseph</name></author><author><name sortKey="Newton, Ru" uniqKey="Newton R">RU Newton</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Iba Ez, J" uniqKey="Iba Ez J">J Ibañez</name></author><author><name sortKey="Izquierdo, M" uniqKey="Izquierdo M">M Izquierdo</name></author><author><name sortKey="Arguelles, I" uniqKey="Arguelles I">I Argüelles</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Miller, Jp" uniqKey="Miller J">JP Miller</name></author><author><name sortKey="Pratley, Re" uniqKey="Pratley R">RE Pratley</name></author><author><name sortKey="Goldberg, Ap" uniqKey="Goldberg A">AP Goldberg</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ryan, As" uniqKey="Ryan A">AS Ryan</name></author><author><name sortKey="Pratley, Re" uniqKey="Pratley R">RE Pratley</name></author><author><name sortKey="Goldberg, Ap" uniqKey="Goldberg A">AP Goldberg</name></author><author><name sortKey="Elahi, D" uniqKey="Elahi D">D Elahi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tchen, N" uniqKey="Tchen N">N Tchen</name></author><author><name sortKey="Juffs, Hg" uniqKey="Juffs H">HG Juffs</name></author><author><name sortKey="Downie, Fp" uniqKey="Downie F">FP Downie</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Irwin, Ml" uniqKey="Irwin M">ML Irwin</name></author><author><name sortKey="Crumley, D" uniqKey="Crumley D">D Crumley</name></author><author><name sortKey="Mctiernan, A" uniqKey="Mctiernan A">A McTiernan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Battaglini, Cl" uniqKey="Battaglini C">CL Battaglini</name></author><author><name sortKey="Hackney, Ac" uniqKey="Hackney A">AC Hackney</name></author><author><name sortKey="Garcia, R" uniqKey="Garcia R">R Garcia</name></author><author><name sortKey="Groff, D" uniqKey="Groff D">D Groff</name></author><author><name sortKey="Evans, E" uniqKey="Evans E">E Evans</name></author><author><name sortKey="Shea, T" uniqKey="Shea T">T Shea</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mustian, Km" uniqKey="Mustian K">KM Mustian</name></author><author><name sortKey="Peppone, L" uniqKey="Peppone L">L Peppone</name></author><author><name sortKey="Darling, Tv" uniqKey="Darling T">TV Darling</name></author><author><name sortKey="Palesh, O" uniqKey="Palesh O">O Palesh</name></author><author><name sortKey="Heckler, Ce" uniqKey="Heckler C">CE Heckler</name></author><author><name sortKey="Morrow, Gr" uniqKey="Morrow G">GR Morrow</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Schmitz, Kh" uniqKey="Schmitz K">KH Schmitz</name></author><author><name sortKey="Ahmed, Rl" uniqKey="Ahmed R">RL Ahmed</name></author><author><name sortKey="Troxel, A" uniqKey="Troxel A">A Troxel</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="review-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">J Aging Res</journal-id><journal-id journal-id-type="publisher-id">JAR</journal-id><journal-title-group><journal-title>Journal of Aging Research</journal-title></journal-title-group><issn pub-type="ppub">2090-2204</issn><issn pub-type="epub">2090-2212</issn><publisher><publisher-name>SAGE-Hindawi Access to Research</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21318049</article-id><article-id pub-id-type="pmc">3034975</article-id><article-id pub-id-type="doi">10.4061/2011/903291</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Intervening on the Side Effects of Hormone-Dependent Cancer Treatment: The Role of Strength Training</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hanson</surname><given-names>Erik D.</given-names></name><xref ref-type="aff" rid="I1"></xref></contrib><contrib contrib-type="author"><name><surname>Hurley</surname><given-names>Ben F.</given-names></name><xref ref-type="aff" rid="I1"></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="I1">Department of Kinesiology, School of Public Health, University of Maryland, College Park, MD 20742, USA</aff><author-notes><corresp id="cor1">*Ben F. Hurley: <email>benhur@umd.edu</email></corresp><fn fn-type="other"><p>Academic Editor: Iris Reuter</p></fn></author-notes><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>13</day><month>1</month><year>2011</year></pub-date><volume>2011</volume><elocation-id>903291</elocation-id><history><date date-type="received"><day>1</day><month>10</month><year>2010</year></date><date date-type="accepted"><day>15</day><month>12</month><year>2010</year></date></history><permissions><copyright-statement>Copyright © 2011 E. D. Hanson and B. F. Hurley.</copyright-statement><copyright-year>2011</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>While prostate and breast cancers are both highly prevalent and treatable using hormone suppression therapy, a constellation of side effects ensue, which mimic typical aging effects but at an accelerated pace. Because strength training is considered to be an intervention of choice for addressing the musculoskeletal and metabolic consequences of normal aging in older adults, it may be an effective intervention to attenuate or reverse the side effects of hormone-dependent cancer treatment. This paper provides an overview of the independent effects of strength training on common musculoskeletal and metabolic side effects of hormone-dependent therapy used for prostate and breast cancers. Strength training appears to be an effective complementary therapy for some of the adverse effects of prostate and breast treatment. Future research needs to address potential mechanisms to explain recent findings and to explore the role of strength training in addressing specific risk factors resulting from cancer treatment.</p></abstract></article-meta></front><body><sec sec-type="section" id="sec1"><title>1. Introduction</title><p>Cancer is the leading cause of death worldwide, accounting for 7.4 million deaths (~13% of all fatalities) in 2004 and is projected to rise to more than 12 million deaths by the year 2030 [<xref ref-type="bibr" rid="B12">1</xref>]. Prostate cancer (PCa) in men (28% of all cancer sites) and breast cancer (BCa) in women (28%) are the most prevalent types of cancer in the US [<xref ref-type="bibr" rid="B43">2</xref>]. They are the second leading causes of cancer-related deaths for men and women in the US, respectively [<xref ref-type="bibr" rid="B43">2</xref>], while BCa is the leading cause of cancer death in women across the globe [<xref ref-type="bibr" rid="B12">1</xref>].</p><p>The prevalence of all cancers increases with age [<xref ref-type="bibr" rid="B43">2</xref>], with those ≥65 years of age accounting for >60% of all cancers [<xref ref-type="bibr" rid="B94">3</xref>]. Because this age group is also more likely to have other comorbid conditions, such as osteoporosis, arthritis, and cardiovascular disease than younger age groups [<xref ref-type="bibr" rid="B94">3</xref>], treatment options become more complicated. Moreover, these patients tend to avoid physical activity, leading to some of the same adverse consequences as those previously experienced by cardiac patients who failed to engage in physical activity [<xref ref-type="bibr" rid="B57">4</xref>]. As is the case for cardiac patients, this course of action can result in losses of functional capacity and quality of life (QoL) measures for cancer patients. In contrast, regular exercise can reduce cancer-related fatigue and other adverse symptoms of the disease, as well as substantially improve the QoL in cancer patients [<xref ref-type="bibr" rid="B57">4</xref>, <xref ref-type="bibr" rid="B20">5</xref>]. Because five-year survival rates in localized PCa and BCa remain high [<xref ref-type="bibr" rid="B43">2</xref>], QoL related issues are of great concern. Although regular exercise has long been recommended for cancer patients, investigators have only recently focused on some of the specific musculoskeletal and metabolic adverse consequences (side effects) of cancer treatment, particularly those of hormone ablation medications.</p><p>There appears to be an interesting parallel between the many side effects of both PCa and BCa treatment and the changes that occur with typical aging [<xref ref-type="bibr" rid="B11">6</xref>–<xref ref-type="bibr" rid="B76">9</xref>], but at an accelerated pace. Given the role of strength training (ST) as a countermeasure for the age-related changes in body composition and physical function [<xref ref-type="bibr" rid="B36">10</xref>], this review will focus on the effects of ST on the side effects elicited from medications used in the two most common hormone-dependent cancers, that is, PCa and BCa. It will not include combined exercise training programs (e.g., those using both aerobic and resistance exercise) unless combined training programs are the only source of information available on the side effect being discussed.</p></sec><sec sec-type="section" id="sec2"><title>2. Treatments for PCa and BCa</title><p>There is a wide variety of treatment options for both PCa and BCa, depending on a patient's medical history, diagnosis, age, and current state of health. Although primary treatment for PCa may include radical prostatectomy, radiation, and other therapies, a common adjuvant treatment is the suppression of endogenous testosterone through the use of hormonal agents [<xref ref-type="bibr" rid="B93">11</xref>]. Likewise, while surgery is the primary therapy for BCa treatment, hormone suppression therapy serves as an important adjuvant therapy [<xref ref-type="bibr" rid="B73">12</xref>]. Chemotherapy is also used as a systemic treatment for BCa, either before surgery (neoadjuvant) or after (adjuvant) as needed. However, a common consequence of chemotherapy is ovarian failure [<xref ref-type="bibr" rid="B74">13</xref>, <xref ref-type="bibr" rid="B80">14</xref>] and the onset of premature menopause.</p><p>Because most PCas are androgen dependent, androgen deprivation therapy (ADT) is a commonly used treatment for PCa [<xref ref-type="bibr" rid="B93">11</xref>] and results in what is sometimes referred to as a chemical castration. Although this treatment slows the growth of existing tumors, thereby potentially saving lives, the associated suppression of testosterone also leads to numerous adverse side effects, including an increase in the number of comorbidities, which ultimately have a negative impact on QoL.</p><p>Analogous to the treatment of PCa, hormonal therapy for the treatment of BCa is to inhibit the effects of estrogen. This can be accomplished using selective estrogen-receptor modulators, such as tamoxifen [<xref ref-type="bibr" rid="B67">15</xref>], or aromatase inhibitors, another example of an antiestrogen treatment [<xref ref-type="bibr" rid="B73">12</xref>]. Both treatments reduce growth in estrogen-responsive tumors. Historically, tamoxifen has been a mainstay in BCa treatment and can be administered to both premenopausal and postmenopausal women [<xref ref-type="bibr" rid="B67">15</xref>] while aromatase inhibitors are typically reserved for postmenopausal women [<xref ref-type="bibr" rid="B73">12</xref>].</p></sec><sec sec-type="section" id="sec3"><title>3. Side Effects of PCa and BCa Therapy and Strength Training</title><sec sec-type="subsection" id="sec3.1"><title>3.1. Does Hormone Therapy Mimic Aging Effects? </title><p>Sex hormone levels decline gradually with age in men and, abruptly, with menopause in women. Previously, the cessation of endogenous production of androgens and estrogens during PCa and BCa treatment has been equated with increases in hormone-dependent age-related changes [<xref ref-type="bibr" rid="B11">6</xref>, <xref ref-type="bibr" rid="B76">9</xref>]. While it is evident that treatment of hormone-dependent cancers via ablation or modulation of the sex hormones is effective in shrinking tumor masses and extending long-term survival rates, such treatments also bring about declines in muscle mass [<xref ref-type="bibr" rid="B10">16</xref>–<xref ref-type="bibr" rid="B83">20</xref>], strength [<xref ref-type="bibr" rid="B3">21</xref>, <xref ref-type="bibr" rid="B28">22</xref>], and bone mineral density (BMD) [<xref ref-type="bibr" rid="B26">17</xref>, <xref ref-type="bibr" rid="B28">22</xref>–<xref ref-type="bibr" rid="B85">27</xref>] and increases in fat mass [<xref ref-type="bibr" rid="B10">16</xref>, <xref ref-type="bibr" rid="B26">17</xref>, <xref ref-type="bibr" rid="B82">19</xref>–<xref ref-type="bibr" rid="B3">21</xref>, <xref ref-type="bibr" rid="B19">28</xref>, <xref ref-type="bibr" rid="B41">29</xref>], insulin resistance [<xref ref-type="bibr" rid="B4">30</xref>–<xref ref-type="bibr" rid="B88">33</xref>], and fatigue [<xref ref-type="bibr" rid="B26">17</xref>, <xref ref-type="bibr" rid="B46">34</xref>–<xref ref-type="bibr" rid="B61">36</xref>]. Collectively, these effects negatively influence physical function [<xref ref-type="bibr" rid="B53">18</xref>, <xref ref-type="bibr" rid="B28">22</xref>, <xref ref-type="bibr" rid="B13">37</xref>–<xref ref-type="bibr" rid="B69">39</xref>] and QoL [<xref ref-type="bibr" rid="B3">21</xref>, <xref ref-type="bibr" rid="B46">34</xref>, <xref ref-type="bibr" rid="B61">36</xref>, <xref ref-type="bibr" rid="B17">40</xref>, <xref ref-type="bibr" rid="B66">41</xref>].</p><p>ST has been advocated as the intervention of choice for addressing many age-related declines [<xref ref-type="bibr" rid="B38">7</xref>, <xref ref-type="bibr" rid="B45">8</xref>]. In this regard, many researchers have demonstrated that ST can reverse age-associated losses in muscle mass [<xref ref-type="bibr" rid="B18">42</xref>, <xref ref-type="bibr" rid="B37">43</xref>], strength [<xref ref-type="bibr" rid="B51">44</xref>], muscle power [<xref ref-type="bibr" rid="B18">42</xref>, <xref ref-type="bibr" rid="B23">45</xref>], bone loss [<xref ref-type="bibr" rid="B71">46</xref>], insulin sensitivity [<xref ref-type="bibr" rid="B81">47</xref>, <xref ref-type="bibr" rid="B86">48</xref>], and increases in regional fat deposition [<xref ref-type="bibr" rid="B89">49</xref>], as well as the deterioration of muscle functional abilities, leading to declines in activities of daily living [<xref ref-type="bibr" rid="B34">50</xref>, <xref ref-type="bibr" rid="B90">51</xref>]. Losses in muscle mass are also associated with declines in resting metabolic rate, which can lead to obesity. In this context, our group has shown increases in resting metabolic rate with ST [<xref ref-type="bibr" rid="B49">52</xref>, <xref ref-type="bibr" rid="B52">53</xref>]. These results from healthy individuals support the hypothesis that ST can reverse or delay the musculoskeletal and metabolic consequences of hormone-dependent cancer treatment. Below is an overview of the evidence from studies that have tested this hypothesis.</p></sec><sec sec-type="subsection" id="sec3.2"><title>3.2. Muscle Mass and Strength</title><p>Significant loss of muscle mass is observed within the first year of ADT in PCa patients [<xref ref-type="bibr" rid="B10">16</xref>, <xref ref-type="bibr" rid="B26">17</xref>, <xref ref-type="bibr" rid="B82">19</xref>, <xref ref-type="bibr" rid="B83">20</xref>], and the longer the treatment period, the greater the loss in muscle mass [<xref ref-type="bibr" rid="B53">18</xref>]. When compared with healthy controls and PCa patients not undergoing ADT, ADT treatment revealed substantial reductions in muscle mass as well as strength [<xref ref-type="bibr" rid="B3">21</xref>, <xref ref-type="bibr" rid="B28">22</xref>]. Ultimately, the loss of muscle mass and strength may be adversely linked to survival because higher levels of muscular strength are associated with lower cancer mortality risk in men, independent of other risk factors [<xref ref-type="bibr" rid="B70">54</xref>]. Declines in strength and mass may also occur in BCa patients during treatment, but the cause of this effect is unclear. In one study involving BCa patients undergoing localized treatment alone versus localized treatment and chemotherapy, there was a slight decline (<0.5 kg) in fat-free mass over 12 months in the dual treatment group while the localized treatment only group increased fat-free mass [<xref ref-type="bibr" rid="B19">28</xref>]. However, this difference was no longer present when results were adjusted for other factors that may have influenced fat-free mass, such as age, race, radiation therapy, baseline body mass index, and baseline fat-free mass. In another study, the effects of chemotherapy and tamoxifen on fat-free mass depended on what method was used to assess fat-free mass [<xref ref-type="bibr" rid="B24">55</xref>]. Other investigators have also observed no treatment effect on fat-free mass [<xref ref-type="bibr" rid="B6">56</xref>, <xref ref-type="bibr" rid="B15">57</xref>] or strength [<xref ref-type="bibr" rid="B77">58</xref>] in BCa patients. Thus, declines in muscle mass and strength appear to be a concern primarily for PCa patients on ADT, given the anabolic role of androgens on muscle mass [<xref ref-type="bibr" rid="B9">59</xref>].</p><p>In two separate randomized trials, Segal et al. [<xref ref-type="bibr" rid="B78">60</xref>, <xref ref-type="bibr" rid="B79">61</xref>] observed strength gains with ST in patients with PCa undergoing ADT. Another study showed that ST improved strength but without changes in whole body fat-free mass in PCa patients on ADT, though a significant increase in quadriceps thickness was reported [<xref ref-type="bibr" rid="B25">62</xref>]. Hansen et al. [<xref ref-type="bibr" rid="B32">63</xref>] examined the muscle hypertrophic response in PCa patients with and without ADT. Using eccentric resistance exercise, the men not on ADT experienced significant regional hypertrophy whereas the men on ADT did not. No significant differences between groups were observed, but the low statistical power from the small sample size may have contributed to this result. In contrast, we recently detected significant increases in thigh muscle volume, directly assessed by computed tomography and whole body fat-free mass with ST in African Americans with PCa on long-term ADT (Hanson et al., unpublished data). BCa patients undergoing treatment are also able to increase their strength levels with ST [<xref ref-type="bibr" rid="B66">41</xref>, <xref ref-type="bibr" rid="B15">57</xref>, <xref ref-type="bibr" rid="B77">58</xref>, <xref ref-type="bibr" rid="B1">64</xref>]. However, many of the existing exercise and cancer studies use a mixture of aerobic and ST protocols, which precludes the independent effects of ST. Nevertheless, it is likely that the strength increases reported in these studies are due to ST, given that aerobic exercise training does not typically result in significant strength increases.</p></sec><sec sec-type="subsection" id="sec3.3"><title>3.3. Muscle Power</title><p>Muscle power is the product of the force and speed of muscular contractions. It is a strong predictor of the ability to perform the activities of daily living necessary for maintaining a high QoL in older adults [<xref ref-type="bibr" rid="B35">65</xref>], to an even greater extent than muscle strength [<xref ref-type="bibr" rid="B7">66</xref>, <xref ref-type="bibr" rid="B8">67</xref>]. For this reason, power has the potential to be an important QoL indicator for patients with cancer. While muscle power declines with advancing age [<xref ref-type="bibr" rid="B59">68</xref>], the effects of cancer therapy on muscle power have not yet been reported in PCa or BCa patients.</p><p>The authors [<xref ref-type="bibr" rid="B18">42</xref>] and others [<xref ref-type="bibr" rid="B23">45</xref>, <xref ref-type="bibr" rid="B47">69</xref>] have reported significant improvements in peak muscle power with ST in older healthy adults. Since movement speed is unlikely to improve with hormone therapy or decline with ST, it is likely that ST would improve power in cancer patients on hormone therapy, as it does for healthy people, given the reported ST-induced strength increases in these patients. To the best of our knowledge, this has not been studied. However, similar to our unpublished muscle volume data, we observed significant improvements in muscle power at various relative loads with ST (Hanson et al., unpublished data).</p></sec><sec sec-type="subsection" id="sec3.4"><title>3.4. Bone Mineral Density</title><p>The hormone therapies used for PCa [<xref ref-type="bibr" rid="B26">17</xref>, <xref ref-type="bibr" rid="B28">22</xref>, <xref ref-type="bibr" rid="B85">27</xref>] and BCa [<xref ref-type="bibr" rid="B67">15</xref>, <xref ref-type="bibr" rid="B77">58</xref>, <xref ref-type="bibr" rid="B56">70</xref>, <xref ref-type="bibr" rid="B68">71</xref>] are both associated with a loss in BMD. However, the specific type of BCa treatment affects BMD differently, as patients on aromatase inhibitors led to declines in BMD while those on tamoxifen experienced significant increases [<xref ref-type="bibr" rid="B14">23</xref>–<xref ref-type="bibr" rid="B22">25</xref>]. Moreover, bone loss associated with aromatase inhibitor treatment in women with BCa is twofold higher than that of healthy, age-matched postmenopausal women [<xref ref-type="bibr" rid="B31">26</xref>]. Chemotherapy treatment for BCa also reduces BMD, probably as a result of ovarian failure, and occurs in ~71% of patients [<xref ref-type="bibr" rid="B74">13</xref>, <xref ref-type="bibr" rid="B80">14</xref>, <xref ref-type="bibr" rid="B77">58</xref>]. Patients who retained ovarian function did not show any loss in BMD [<xref ref-type="bibr" rid="B80">14</xref>]. With the possible exception of fatigue, BMD loss and fracture risk appear to be the single largest consequence of BCa treatment.</p><p>We could find only one study each for PCa and BCa reporting the effects of ST on bone mass [<xref ref-type="bibr" rid="B77">58</xref>, <xref ref-type="bibr" rid="B25">62</xref>]. ST for 20 weeks did not result in any changes in BMD in PCa patients [<xref ref-type="bibr" rid="B25">62</xref>]. In a randomized clinical trial of BCa patients, six months of home-based aerobic training versus resistance training versus usual care, demonstrated BMD declines of −0.76%, −4.92%, and −6.23%, respectively, with only a significant difference between the aerobic training and usual care groups [<xref ref-type="bibr" rid="B77">58</xref>]. However, the ST program was performed using Thera-Bands and light resistance. Recently, Newton et al. [<xref ref-type="bibr" rid="B65">72</xref>] proposed a study that could potentially be the best controlled and most thorough physiological investigation on ST effects in patients on ADT. In particular, they propose to address the impact of ST on bone density as an indicator of fracture risk. They will also determine the effects of impact-loading exercise on bone mass. The rationale for this latter aspect of their study is that high and frequent impact forces on long bones are thought to stimulate bone formation.</p><p>Despite the lack of direct evidence of significant improvements in BMD in cancer patients, ST can increase BMD in healthy older adults [<xref ref-type="bibr" rid="B71">46</xref>, <xref ref-type="bibr" rid="B55">73</xref>–<xref ref-type="bibr" rid="B63">75</xref>]. Although not all studies report improvements, those that have compared ST results to controls support the hypothesis that ST is effective for preventing or delaying the loss of BMD over time in older adults. Therefore, it is logical that a similar effect could be present in cancer patients if sufficient intensities are used, despite limited evidence to the contrary [<xref ref-type="bibr" rid="B77">58</xref>]. While increases in BMD directly reduce fracture risk, it has been argued that the ST-induced gains (<5%) are not sufficient to overcome the estimated 20% gain in BMD that may be necessary to actually prevent a fracture during falls [<xref ref-type="bibr" rid="B16">76</xref>]. Instead, ST may indirectly reduce fracture risk by improving walking mechanics, balance, and strength, some of which have been observed in PCa patients during treatment [<xref ref-type="bibr" rid="B25">62</xref>], leading to a reduced risk of falling.</p></sec><sec sec-type="subsection" id="sec3.5"><title>3.5. Fat Mass</title><p>Unlike fat-free mass, treatment of both PCa [<xref ref-type="bibr" rid="B10">16</xref>–<xref ref-type="bibr" rid="B83">20</xref>, <xref ref-type="bibr" rid="B79">61</xref>, <xref ref-type="bibr" rid="B2">77</xref>] and BCa [<xref ref-type="bibr" rid="B19">28</xref>, <xref ref-type="bibr" rid="B41">29</xref>, <xref ref-type="bibr" rid="B24">55</xref>] is consistently associated with a significant increase in fat deposition. The increase in fat mass can lead to obesity, diabetes, and metabolic syndrome. Although not directly assessed in previous cancer studies, it is quite likely that PCa and BCa therapies increase fat infiltration in muscle, leading to the accumulation of intermuscular fat [<xref ref-type="bibr" rid="B42">78</xref>]. This too has important health implications because elevated levels of intermuscular fat have been linked to insulin resistance and to the development of type 2 diabetes [<xref ref-type="bibr" rid="B30">79</xref>]. In addition, fat infiltration is associated with reduced strength [<xref ref-type="bibr" rid="B29">80</xref>], poorer leg function [<xref ref-type="bibr" rid="B92">81</xref>], and greater incidence of mobility limitations in older adults [<xref ref-type="bibr" rid="B91">82</xref>]. While weight gain is widely reported with BCa treatment, it is not well established if the gain is specifically due to tamoxifen. In a cohort of women who experienced weight gain of 1.7 kg and increased body fat 2.1%, there were no differences in weight and percent body fat increases between those being treated with tamoxifen and those who were not [<xref ref-type="bibr" rid="B41">29</xref>].</p><p>Segal et al. [<xref ref-type="bibr" rid="B79">61</xref>] found that ST may play a preventative role against the increase in body fat associated with PCa treatment. The patients who performed ST had no change in fat mass while those in the control group experienced significant increases in fat mass. Along these same lines, Galvão et al. [<xref ref-type="bibr" rid="B25">62</xref>] reported no change in body fat with ST and ADT, but had no control group for comparison. Similar findings of no significant reductions in body fat have been reported in BCa [<xref ref-type="bibr" rid="B15">57</xref>]. Mixed training protocols (ST and aerobic exercise training) can result in a significant loss of fat mass in some [<xref ref-type="bibr" rid="B6">56</xref>] but not all [<xref ref-type="bibr" rid="B54">83</xref>] studies in BCa patients during treatment.</p></sec><sec sec-type="subsection" id="sec3.6"><title>3.6. Insulin Resistance</title><p>Insulin resistance refers to a reduction in the effectiveness of glucose uptake. This defect is linked to a whole spectrum of disorders, including obesity, cardiovascular disease, and the metabolic syndrome. Basaria et al. [<xref ref-type="bibr" rid="B4">30</xref>] observed a substantially higher prevalence of insulin resistance in PCa patients on ADT than in two other control groups, one in normal healthy controls and the other in a group having a similar disease state, but not on ADT. These results were independent of age and obesity. Similar declines in insulin sensitivity were found after a 12-week prospective study at the onset of ADT [<xref ref-type="bibr" rid="B84">32</xref>]. In addition, two independent reviews have corroborated this conclusion showing a strong link between ADT administration and insulin resistance [<xref ref-type="bibr" rid="B2">77</xref>, <xref ref-type="bibr" rid="B48">84</xref>] and that this association becomes evident within the first few months of treatment. The authors emphasize the need for men receiving ADT to develop healthy lifestyle practices, such as regular exercise, particularly ST [<xref ref-type="bibr" rid="B48">84</xref>]. Furthermore, Basaria [<xref ref-type="bibr" rid="B2">77</xref>] found that ADT use for 12 months revealed a higher prevalence of diabetes, metabolic syndrome, and death from cardiovascular disease compared to controls. Similar to PCa patients, BCa patients on hormone therapy also have elevated insulin, glucose, and HbA1c levels [<xref ref-type="bibr" rid="B88">33</xref>]. Moreover, low doses of hormone therapy result in a loss of insulin sensitivity in women at a high risk for BCa [<xref ref-type="bibr" rid="B44">31</xref>]. Women being treated for BCa also had higher C-reactive protein levels and incidence rates of metabolic syndrome [<xref ref-type="bibr" rid="B88">33</xref>, <xref ref-type="bibr" rid="B33">85</xref>].</p><p>To the best of our knowledge, however, the independent effect of ST has not been studied in cancer patients undergoing treatment for hormone-dependent cancers. The best evidence available is that BCa patients who underwent supervised ST and home-based aerobic exercise had significant decreases in fasting insulin levels with no change in the control group [<xref ref-type="bibr" rid="B54">83</xref>]. There was only a trend for between-group differences and no change in fasting glucose levels were found. Patients on ADT undergoing a mixed training protocol had no adjusted group differences after 12 weeks of training for insulin or glucose [<xref ref-type="bibr" rid="B27">86</xref>]. In healthy individuals, ST reduces insulin resistance and is as effective as aerobic training in both healthy older adults [<xref ref-type="bibr" rid="B86">48</xref>] and diabetics [<xref ref-type="bibr" rid="B81">47</xref>]. ST improves the insulin responses during oral glucose tolerance testing and hyperinsulinemic-euglycemic clamps in older men [<xref ref-type="bibr" rid="B39">87</xref>, <xref ref-type="bibr" rid="B60">88</xref>] and postmenopausal women [<xref ref-type="bibr" rid="B72">89</xref>]. The similarity of findings between ST effects in healthy older adults and those undergoing cancer treatments for other risk factors supports the hypothesis that ST would also produce improvements in insulin resistance in cancer survivors. The data available do not entirely support this, but the independent effects of ST have yet to be evaluated.</p></sec><sec sec-type="subsection" id="sec3.7"><title>3.7. Fatigue and Physical Activity Levels</title><p>Fatigue may be the most prevalent and distressing side effect during and after cancer treatment [<xref ref-type="bibr" rid="B57">4</xref>, <xref ref-type="bibr" rid="B20">5</xref>], as high numbers of patients report suffering from chronic fatigue during this time [<xref ref-type="bibr" rid="B26">17</xref>, <xref ref-type="bibr" rid="B46">34</xref>–<xref ref-type="bibr" rid="B61">36</xref>, <xref ref-type="bibr" rid="B24">55</xref>, <xref ref-type="bibr" rid="B87">90</xref>]. It is likely that both aging and hormone therapy contribute to fatigue by eliciting physiological events (such as anemia, declines in strength and fat-free mass, and increased fat mass) that promote loss in fatigue resistance and the ability or willingness to engage in physical activity. Both PCa and BCa patients have reduced physical activity levels after the onset of treatment [<xref ref-type="bibr" rid="B26">17</xref>, <xref ref-type="bibr" rid="B40">91</xref>]. Lower levels of physical activity, in part, result in overall reductions in fitness levels, leading to declines in physical function and ultimately to loss in QoL.</p><p>Compliance to regular exercise may break the vicious cycle of fatigue followed by avoidance of physical activity [<xref ref-type="bibr" rid="B57">4</xref>, <xref ref-type="bibr" rid="B20">5</xref>]. Segal et al. [<xref ref-type="bibr" rid="B78">60</xref>, <xref ref-type="bibr" rid="B79">61</xref>] found that fatigue negatively impacts on activities of daily living and QoL measures but both were improved as a result of ST in men with PCa. They also observed improvements in muscle endurance with the ST group compared to a control group [<xref ref-type="bibr" rid="B78">60</xref>]. This finding has been corroborated by others [<xref ref-type="bibr" rid="B25">62</xref>], supporting the hypothesis that ST improves fatigue resistance in patients undergoing ADT. Reductions in fatigue with ST have also been observed in patients being treated for BCa [<xref ref-type="bibr" rid="B15">57</xref>], but these reductions were not significantly different from those of a control group. As described for other factors previously, the independent effects of ST are not entirely clear because many studies used both aerobic and ST [<xref ref-type="bibr" rid="B61">36</xref>, <xref ref-type="bibr" rid="B5">92</xref>, <xref ref-type="bibr" rid="B62">93</xref>]. There is little doubt, however, that regular exercise reduces fatigue in BCa patients undergoing therapy.</p></sec><sec sec-type="subsection" id="sec3.8"><title>3.8. Physical Function</title><p>The loss of physical function during ADT treatment is a common side effect [<xref ref-type="bibr" rid="B53">18</xref>, <xref ref-type="bibr" rid="B28">22</xref>, <xref ref-type="bibr" rid="B13">37</xref>] and is likely the result of decreased muscle mass and physical activity levels coupled with increases in fat mass and fatigue. Investigators who study functional abilities in men with PCa often administer a standardized battery of tests that simulate activities of daily living. This form of testing is seldom reported in women with BCa, rather the declines in function often focus on shoulder dysfunction and lymphedema following surgery rather than hormone treatments [<xref ref-type="bibr" rid="B69">39</xref>] or assess function via questionnaire. Reduced shoulder function in BCa is associated with poorer physical condition, minimal physical activity, increased body mass index, and poorer physical QoL [<xref ref-type="bibr" rid="B64">38</xref>], similar to the loss of function and QoL associated with PCa.</p><p>ST in men on ADT led to reported improvements of 7 to 27% in simulated activities of daily living [<xref ref-type="bibr" rid="B25">62</xref>]. Others have also reported improved activities of daily living in men with PCa but have used either combined exercise programs or resistance in which only the lengthening phase of the exercise is loaded (eccentric) [<xref ref-type="bibr" rid="B32">63</xref>, <xref ref-type="bibr" rid="B27">86</xref>]. Studies on the effects of ST on upper body function are limited in BCa patients, possibly because ST was previously contraindicated due to concerns of lymphedema. However, recent studies have specifically addressed this concern. While no data are available on physical function, adverse events and worsening of lymphedema symptoms did not occur with ST [<xref ref-type="bibr" rid="B15">57</xref>, <xref ref-type="bibr" rid="B1">64</xref>, <xref ref-type="bibr" rid="B75">94</xref>]. The fact that women with BCa can safely participate in this type of exercise without adverse consequences provides a rationale for future studies to examine the role of ST on upper body function given the connection between limited function and QoL [<xref ref-type="bibr" rid="B64">38</xref>].</p></sec><sec sec-type="subsection" id="sec3.9"><title>3.9. Quality of Life</title><p>Quality of life is arguably the most egregious side effect resulting from cancer treatment and is intertwined with strength, body composition, fatigue, and physical function. The changes observed with cancer treatment to the above traits are likely to influence QoL. Thus, it is not surprising that men and women undergoing hormone therapy for PCa and BCa report reduced QoL indicators [<xref ref-type="bibr" rid="B3">21</xref>, <xref ref-type="bibr" rid="B46">34</xref>, <xref ref-type="bibr" rid="B61">36</xref>, <xref ref-type="bibr" rid="B17">40</xref>, <xref ref-type="bibr" rid="B66">41</xref>]. The questionnaires used to assess QoL varied between studies, although several trends appear to be evident. For example, lower QoL scores were observed for the physical function but not the mental health in both PCa and BCa patients [<xref ref-type="bibr" rid="B3">21</xref>, <xref ref-type="bibr" rid="B17">40</xref>, <xref ref-type="bibr" rid="B66">41</xref>]. Other studies that used QoL questionnaires specific to each cancer type demonstrated reduced overall scores with treatment [<xref ref-type="bibr" rid="B46">34</xref>, <xref ref-type="bibr" rid="B61">36</xref>]. Improved QoL scores with ST are observed in some studies in PCa and BCa patient populations [<xref ref-type="bibr" rid="B66">41</xref>, <xref ref-type="bibr" rid="B78">60</xref>, <xref ref-type="bibr" rid="B79">61</xref>], though not in others [<xref ref-type="bibr" rid="B15">57</xref>, <xref ref-type="bibr" rid="B32">63</xref>]. Moreover, Ohira et al. [<xref ref-type="bibr" rid="B66">41</xref>] reported that several musculoskeletal improvements with ST were correlated with higher QoL indicators.</p></sec></sec><sec sec-type="section" id="sec4"><title>4. Conclusions and Future Directions</title><p>Some of the effects of hormone-related treatments for persons with PCa and BCa are similar to the typical effects of normal aging but occur at an accelerated pace. These include a long list of musculoskeletal, metabolic, body composition, and functional outcomes. ST appears to have a positive influence on many, but not all of these characteristics. In particular, ST is effective in reversing the loss of strength and function and may be able to slow fat gains and bone losses common to both types of cancer treatments. Due to the widespread use of mixed training protocols, there are some side effects that are reduced from training, but the independent effects of ST cannot be distinguished from effects of other training modalities, such as aerobic exercise. With five-year survival rates for BCa and PCa approaching 100% [<xref ref-type="bibr" rid="B43">2</xref>], maintaining high QoL in cancer patients is of paramount importance. In this regard, ST may contribute toward achieving this goal by serving as an effective adjunct therapy and countermeasure to the adverse effects of PCa and BCa treatment.</p><p>Over the past decade, the role of exercise has expanded from a means of improving QoL in cancer patients toward addressing specific risk factors resulting from cancer treatment, as well other lifestyle choices that limit function and influence QoL. Future research should address the issue of whether ST can (1) reverse ADT-induced muscle atrophy through direct assessments of muscle area in PCa patients, (2) enhance direct measures of whole body physical function in BCa patients, (3) improve muscle power and bone mineral densities in both populations, and (4) establish a relationship between favorable functional outcomes (activities of daily living, fatigue, QoL) and specific ST-induced adaptations (strength, power, body composition). This additional information will help guide clinicians in exercise prescription designed specifically to reduce comorbidities and particular side effects to enhance QoL in men and women undergoing hormone treatment for PCa and BCa, respectively.</p></sec></body><back><ref-list><ref id="B12"><label>1</label><element-citation publication-type="other"><collab>World Health Organization</collab><article-title>Cancer Facts Sheet</article-title><comment>Geneva, Switzerland, September 2010, <ext-link ext-link-type="uri" xlink:href="http://www.who.int/mediacentre/factsheets/fs297/en/index.html">http://www.who.int/mediacentre/ factsheets/fs297/en/index.html</ext-link></comment></element-citation></ref><ref id="B43"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jemal</surname><given-names>A</given-names></name><name><surname>Siegel</surname><given-names>R</given-names></name><name><surname>Ward</surname><given-names>E</given-names></name></person-group><article-title>Cancer statistics, 2010</article-title><source><italic>CA Cancer Journal for Clinicians</italic></source><year>2010</year><volume>60</volume><fpage>277</fpage><lpage>300</lpage></element-citation></ref><ref id="B94"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yancik</surname><given-names>R</given-names></name></person-group><article-title>Cancer burden in the aged: an epidemiologic and demographic overview</article-title><source><italic>Cancer</italic></source><year>1997</year><volume>80</volume><issue>7</issue><fpage>1273</fpage><lpage>1283</lpage><pub-id pub-id-type="pmid">9317180</pub-id></element-citation></ref><ref id="B57"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucía</surname><given-names>A</given-names></name><name><surname>Earnest</surname><given-names>C</given-names></name><name><surname>Pérez</surname><given-names>M</given-names></name></person-group><article-title>Cancer-related fatigue: can exercise physiology assist oncologists?</article-title><source><italic>Lancet Oncology</italic></source><year>2003</year><volume>4</volume><issue>10</issue><fpage>616</fpage><lpage>625</lpage><pub-id pub-id-type="pmid">14554239</pub-id></element-citation></ref><ref id="B20"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dimeo</surname><given-names>FC</given-names></name></person-group><article-title>Effects of exercise on cancer-related fatigue</article-title><source><italic>Cancer</italic></source><year>2001</year><volume>92</volume><issue>6</issue><fpage>1689</fpage><lpage>1693</lpage><pub-id pub-id-type="pmid">11598888</pub-id></element-citation></ref><ref id="B11"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bylow</surname><given-names>K</given-names></name><name><surname>Mohile</surname><given-names>SG</given-names></name><name><surname>Stadler</surname><given-names>WM</given-names></name><name><surname>Dale</surname><given-names>W</given-names></name></person-group><article-title>Does Androgen-deprivation therapy accelerate the development of frailty in older men with prostate cancer? A conceptual review</article-title><source><italic>Cancer</italic></source><year>2007</year><volume>110</volume><issue>12</issue><fpage>2604</fpage><lpage>2613</lpage><pub-id pub-id-type="pmid">17960609</pub-id></element-citation></ref><ref id="B38"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurley</surname><given-names>BF</given-names></name><name><surname>Roth</surname><given-names>SM</given-names></name></person-group><article-title>Strength training in the elderly: effects on risk factors for age-related diseases</article-title><source><italic>Sports Medicine</italic></source><year>2000</year><volume>30</volume><issue>4</issue><fpage>249</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">11048773</pub-id></element-citation></ref><ref id="B45"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>APW</given-names></name><name><surname>De Lisio</surname><given-names>M</given-names></name><name><surname>Parise</surname><given-names>G</given-names></name></person-group><article-title>Resistance training, sarcopenia, and the mitochondrial theory of aging</article-title><source><italic>Applied Physiology, Nutrition and Metabolism</italic></source><year>2008</year><volume>33</volume><issue>1</issue><fpage>191</fpage><lpage>199</lpage></element-citation></ref><ref id="B76"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitz</surname><given-names>KH</given-names></name><name><surname>Cappola</surname><given-names>AR</given-names></name><name><surname>Stricker</surname><given-names>CT</given-names></name><name><surname>Sweeney</surname><given-names>C</given-names></name><name><surname>Norman</surname><given-names>SA</given-names></name></person-group><article-title>The intersection of cancer and aging: establishing the need for breast cancer rehabilitation</article-title><source><italic>Cancer Epidemiology Biomarkers and Prevention</italic></source><year>2007</year><volume>16</volume><issue>5</issue><fpage>866</fpage><lpage>872</lpage></element-citation></ref><ref id="B36"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurley</surname><given-names>BF</given-names></name><name><surname>Hanson</surname><given-names>ED</given-names></name><name><surname>Sheaff</surname><given-names>AK</given-names></name></person-group><article-title>Strength training as a countermeasure to aging muscle and chronic disease</article-title><comment><italic>Sports Medicine</italic>. In press</comment></element-citation></ref><ref id="B93"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>MB</given-names></name><name><surname>Hernandez</surname><given-names>J</given-names></name><name><surname>Thompson</surname><given-names>I</given-names></name></person-group><article-title>Luteinizing hormone-releasing hormone agonist effects on skeletal muscle: how hormonal therapy in prostate cancer affects muscular strength</article-title><source><italic>Journal of Urology</italic></source><year>2005</year><volume>173</volume><issue>4</issue><fpage>1067</fpage><lpage>1071</lpage><pub-id pub-id-type="pmid">15758703</pub-id></element-citation></ref><ref id="B73"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>PD</given-names></name><name><surname>Goss</surname><given-names>PE</given-names></name></person-group><article-title>Adjuvant hormonal therapy in peri- and postmenopausal breast cancer</article-title><source><italic>Oncologist</italic></source><year>2006</year><volume>11</volume><issue>7</issue><fpage>718</fpage><lpage>731</lpage><pub-id pub-id-type="pmid">16880231</pub-id></element-citation></ref><ref id="B74"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saarto</surname><given-names>T</given-names></name><name><surname>Blomqvist</surname><given-names>C</given-names></name><name><surname>Välimäki</surname><given-names>M</given-names></name><name><surname>Mäkelä</surname><given-names>P</given-names></name><name><surname>Sarna</surname><given-names>S</given-names></name><name><surname>Elomaa</surname><given-names>I</given-names></name></person-group><article-title>Chemical castration induced by adjuvant cyciophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients</article-title><source><italic>Journal of Clinical Oncology</italic></source><year>1997</year><volume>15</volume><issue>4</issue><fpage>1341</fpage><lpage>1347</lpage><pub-id pub-id-type="pmid">9193325</pub-id></element-citation></ref><ref id="B80"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapiro</surname><given-names>CL</given-names></name><name><surname>Manola</surname><given-names>J</given-names></name><name><surname>Leboff</surname><given-names>M</given-names></name></person-group><article-title>Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer</article-title><source><italic>Journal of Clinical Oncology</italic></source><year>2001</year><volume>19</volume><issue>14</issue><fpage>3306</fpage><lpage>3311</lpage><pub-id pub-id-type="pmid">11454877</pub-id></element-citation></ref><ref id="B67"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osborne</surname><given-names>CK</given-names></name></person-group><article-title>Tamoxifen in the treatment of breast cancer</article-title><source><italic>New England Journal of Medicine</italic></source><year>1998</year><volume>339</volume><issue>22</issue><fpage>1609</fpage><lpage>1618</lpage><pub-id pub-id-type="pmid">9828250</pub-id></element-citation></ref><ref id="B10"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boxer</surname><given-names>RS</given-names></name><name><surname>Kenny</surname><given-names>AM</given-names></name><name><surname>Dowsett</surname><given-names>R</given-names></name><name><surname>Taxel</surname><given-names>P</given-names></name></person-group><article-title>The effect of 6 months of androgen deprivation therapy on muscle and fat mass in older men with localized prostate cancer</article-title><source><italic>Aging Male</italic></source><year>2005</year><volume>8</volume><issue>3-4</issue><fpage>207</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">16390748</pub-id></element-citation></ref><ref id="B26"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galvão</surname><given-names>DA</given-names></name><name><surname>Spry</surname><given-names>NA</given-names></name><name><surname>Taaffe</surname><given-names>DR</given-names></name><etal></etal></person-group><article-title>Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer</article-title><source><italic>BJU International</italic></source><year>2008</year><volume>102</volume><issue>1</issue><fpage>44</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">18336606</pub-id></element-citation></ref><ref id="B53"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>ME</given-names></name><name><surname>Perera</surname><given-names>S</given-names></name><name><surname>van Londen</surname><given-names>GJ</given-names></name><name><surname>Nelson</surname><given-names>JB</given-names></name><name><surname>Clay</surname><given-names>CA</given-names></name><name><surname>Greenspan</surname><given-names>SL</given-names></name></person-group><article-title>Physical function changes in prostate cancer patients on androgen deprivation therapy: a 2-year prospective study</article-title><source><italic>Urology</italic></source><year>2008</year><volume>71</volume><issue>4</issue><fpage>735</fpage><lpage>739</lpage><pub-id pub-id-type="pmid">18279933</pub-id></element-citation></ref><ref id="B82"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>MR</given-names></name></person-group><article-title>Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer</article-title><source><italic>Urology</italic></source><year>2004</year><volume>63</volume><issue>4</issue><fpage>742</fpage><lpage>745</lpage><pub-id pub-id-type="pmid">15072892</pub-id></element-citation></ref><ref id="B83"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>MR</given-names></name><name><surname>Finkelstein</surname><given-names>JS</given-names></name><name><surname>McGovern</surname><given-names>FJ</given-names></name><etal></etal></person-group><article-title>Changes in body composition during androgen deprivation therapy for prostate cancer</article-title><source><italic>Journal of Clinical Endocrinology and Metabolism</italic></source><year>2002</year><volume>87</volume><issue>2</issue><fpage>599</fpage><lpage>603</lpage><pub-id pub-id-type="pmid">11836291</pub-id></element-citation></ref><ref id="B3"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basaria</surname><given-names>S</given-names></name><name><surname>Lieb</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>AM</given-names></name><etal></etal></person-group><article-title>Long-term effects of androgen deprivation therapy in prostate cancer patients</article-title><source><italic>Clinical Endocrinology</italic></source><year>2002</year><volume>56</volume><issue>6</issue><fpage>779</fpage><lpage>786</lpage><pub-id pub-id-type="pmid">12072048</pub-id></element-citation></ref><ref id="B28"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galvão</surname><given-names>DA</given-names></name><name><surname>Taaffe</surname><given-names>DR</given-names></name><name><surname>Spry</surname><given-names>N</given-names></name><name><surname>Joseph</surname><given-names>D</given-names></name><name><surname>Turner</surname><given-names>D</given-names></name><name><surname>Newton</surname><given-names>RU</given-names></name></person-group><article-title>Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation</article-title><source><italic>Prostate Cancer and Prostatic Diseases</italic></source><year>2009</year><volume>12</volume><issue>2</issue><fpage>198</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">18852703</pub-id></element-citation></ref><ref id="B14"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>RE</given-names></name><name><surname>Banks</surname><given-names>LM</given-names></name><name><surname>Girgis</surname><given-names>SI</given-names></name><etal></etal></person-group><article-title>Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study</article-title><source><italic>Lancet Oncology</italic></source><year>2007</year><volume>8</volume><issue>2</issue><fpage>119</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">17267326</pub-id></element-citation></ref><ref id="B21"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eastell</surname><given-names>R</given-names></name><name><surname>Adams</surname><given-names>JE</given-names></name><name><surname>Coleman</surname><given-names>RE</given-names></name><etal></etal></person-group><article-title>Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230</article-title><source><italic>Journal of Clinical Oncology</italic></source><year>2008</year><volume>26</volume><issue>7</issue><fpage>1051</fpage><lpage>1058</lpage><pub-id pub-id-type="pmid">18309940</pub-id></element-citation></ref><ref id="B22"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eastell</surname><given-names>R</given-names></name><name><surname>Hannon</surname><given-names>RA</given-names></name><name><surname>Cuzick</surname><given-names>J</given-names></name><name><surname>Dowsett</surname><given-names>M</given-names></name><name><surname>Clack</surname><given-names>G</given-names></name><name><surname>Adams</surname><given-names>JE</given-names></name></person-group><article-title>Effect of an aromatase inhibitor on BMD and bone turnover markers: 2-Year results of the anastrozole, tamoxifen, alone or in combination (ATAC) trial (18233230)</article-title><source><italic>Journal of Bone and Mineral Research</italic></source><year>2006</year><volume>21</volume><issue>8</issue><fpage>1215</fpage><lpage>1223</lpage><pub-id pub-id-type="pmid">16869719</pub-id></element-citation></ref><ref id="B31"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hadji</surname><given-names>P</given-names></name><name><surname>Body</surname><given-names>JJ</given-names></name><name><surname>Aapro</surname><given-names>MS</given-names></name><etal></etal></person-group><article-title>Practical guidance for the management of aromatase inhibitor-associated bone loss</article-title><source><italic>Annals of Oncology</italic></source><year>2008</year><volume>19</volume><issue>8</issue><fpage>1407</fpage><lpage>1416</lpage><pub-id pub-id-type="pmid">18448451</pub-id></element-citation></ref><ref id="B85"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>MR</given-names></name><name><surname>Lee</surname><given-names>WC</given-names></name><name><surname>Brandman</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Botteman</surname><given-names>M</given-names></name><name><surname>Pashos</surname><given-names>CL</given-names></name></person-group><article-title>Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer</article-title><source><italic>Journal of Clinical Oncology</italic></source><year>2005</year><volume>23</volume><issue>31</issue><fpage>7897</fpage><lpage>7903</lpage><pub-id pub-id-type="pmid">16258089</pub-id></element-citation></ref><ref id="B19"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demark-Wahnefried</surname><given-names>W</given-names></name><name><surname>Peterson</surname><given-names>BL</given-names></name><name><surname>Winer</surname><given-names>EP</given-names></name><etal></etal></person-group><article-title>Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy</article-title><source><italic>Journal of Clinical Oncology</italic></source><year>2001</year><volume>19</volume><issue>9</issue><fpage>2381</fpage><lpage>2389</lpage><pub-id pub-id-type="pmid">11331316</pub-id></element-citation></ref><ref id="B41"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irwin</surname><given-names>ML</given-names></name><name><surname>McTiernan</surname><given-names>A</given-names></name><name><surname>Baumgartner</surname><given-names>RN</given-names></name><etal></etal></person-group><article-title>Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors</article-title><source><italic>Journal of Clinical Oncology</italic></source><year>2005</year><volume>23</volume><issue>4</issue><fpage>774</fpage><lpage>782</lpage><pub-id pub-id-type="pmid">15681521</pub-id></element-citation></ref><ref id="B4"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basaria</surname><given-names>S</given-names></name><name><surname>Muller</surname><given-names>DC</given-names></name><name><surname>Carducci</surname><given-names>MA</given-names></name><name><surname>Egan</surname><given-names>J</given-names></name><name><surname>Dobs</surname><given-names>AS</given-names></name></person-group><article-title>Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy</article-title><source><italic>Cancer</italic></source><year>2006</year><volume>106</volume><issue>3</issue><fpage>581</fpage><lpage>588</lpage><pub-id pub-id-type="pmid">16388523</pub-id></element-citation></ref><ref id="B44"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>H</given-names></name><name><surname>Gandini</surname><given-names>S</given-names></name><name><surname>Guerrieri-Gonzaga</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer</article-title><source><italic>Cancer Research</italic></source><year>2008</year><volume>68</volume><issue>22</issue><fpage>9512</fpage><lpage>9518</lpage><pub-id pub-id-type="pmid">19010927</pub-id></element-citation></ref><ref id="B84"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>MR</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Nathan</surname><given-names>DM</given-names></name></person-group><article-title>Insulin sensitivity during combined androgen blockade for prostate cancer</article-title><source><italic>Journal of Clinical Endocrinology and Metabolism</italic></source><year>2006</year><volume>91</volume><issue>4</issue><fpage>1305</fpage><lpage>1308</lpage><pub-id pub-id-type="pmid">16434464</pub-id></element-citation></ref><ref id="B88"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomson</surname><given-names>CA</given-names></name><name><surname>Thompson</surname><given-names>PA</given-names></name><name><surname>Wright-Bea</surname><given-names>J</given-names></name><name><surname>Nardi</surname><given-names>E</given-names></name><name><surname>Frey</surname><given-names>GR</given-names></name><name><surname>Stopeck</surname><given-names>A</given-names></name></person-group><article-title>Metabolic syndrome and elevated C-reactive protein in breast cancer survivors on adjuvant hormone therapy</article-title><source><italic>Journal of Women’s Health</italic></source><year>2009</year><volume>18</volume><issue>12</issue><fpage>2041</fpage><lpage>2047</lpage></element-citation></ref><ref id="B46"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joly</surname><given-names>F</given-names></name><name><surname>Alibhai</surname><given-names>SMH</given-names></name><name><surname>Galica</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer</article-title><source><italic>Journal of Urology</italic></source><year>2006</year><volume>176</volume><issue>6</issue><fpage>2443</fpage><lpage>2447</lpage><pub-id pub-id-type="pmid">17085125</pub-id></element-citation></ref><ref id="B50"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kyrdalen</surname><given-names>AE</given-names></name><name><surname>Dahl</surname><given-names>AA</given-names></name><name><surname>Hernes</surname><given-names>E</given-names></name><name><surname>Hem</surname><given-names>E</given-names></name><name><surname>Fosså</surname><given-names>SD</given-names></name></person-group><article-title>Fatigue in prostate cancer survivors treated with definitive radiotherapy and LHRH analogs</article-title><source><italic>Prostate</italic></source><year>2010</year><volume>70</volume><issue>13</issue><fpage>1480</fpage><lpage>1489</lpage><pub-id pub-id-type="pmid">20687221</pub-id></element-citation></ref><ref id="B61"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milne</surname><given-names>HM</given-names></name><name><surname>Wallman</surname><given-names>KE</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name><name><surname>Courneya</surname><given-names>KS</given-names></name></person-group><article-title>Effects of a combined aerobic and resistance exercise program in breast cancer survivors: a randomized controlled trial</article-title><source><italic>Breast Cancer Research and Treatment</italic></source><year>2008</year><volume>108</volume><issue>2</issue><fpage>279</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">17530428</pub-id></element-citation></ref><ref id="B13"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clay</surname><given-names>CA</given-names></name><name><surname>Perera</surname><given-names>S</given-names></name><name><surname>Wagner</surname><given-names>JM</given-names></name><name><surname>Miller</surname><given-names>ME</given-names></name><name><surname>Nelson</surname><given-names>JB</given-names></name><name><surname>Greenspan</surname><given-names>SL</given-names></name></person-group><article-title>Physical function in men with prostate cancer on androgen deprivation therapy</article-title><source><italic>Physical Therapy</italic></source><year>2007</year><volume>87</volume><issue>10</issue><fpage>1325</fpage><lpage>1333</lpage><pub-id pub-id-type="pmid">17684084</pub-id></element-citation></ref><ref id="B64"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nesvold</surname><given-names>IL</given-names></name><name><surname>Foss</surname><given-names>SD</given-names></name><name><surname>Holm</surname><given-names>I</given-names></name><name><surname>Naume</surname><given-names>B</given-names></name><name><surname>Dahl</surname><given-names>AA</given-names></name></person-group><article-title>Arm/shoulder problems in breast cancer survivors are associated with reduced health and poorer physical quality of life</article-title><source><italic>Acta Oncologica</italic></source><year>2010</year><volume>49</volume><issue>3</issue><fpage>347</fpage><lpage>353</lpage><pub-id pub-id-type="pmid">19842790</pub-id></element-citation></ref><ref id="B69"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rietman</surname><given-names>JS</given-names></name><name><surname>Dijkstra</surname><given-names>PU</given-names></name><name><surname>Hoekstra</surname><given-names>HJ</given-names></name><etal></etal></person-group><article-title>Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review</article-title><source><italic>European Journal of Surgical Oncology</italic></source><year>2003</year><volume>29</volume><issue>3</issue><fpage>229</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">12657232</pub-id></element-citation></ref><ref id="B17"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dacal</surname><given-names>K</given-names></name><name><surname>Sereika</surname><given-names>SM</given-names></name><name><surname>Greenspan</surname><given-names>SL</given-names></name></person-group><article-title>Quality of life in prostate cancer patients taking androgen deprivation therapy</article-title><source><italic>Journal of the American Geriatrics Society</italic></source><year>2006</year><volume>54</volume><issue>1</issue><fpage>85</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">16420202</pub-id></element-citation></ref><ref id="B66"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohira</surname><given-names>T</given-names></name><name><surname>Schmitz</surname><given-names>KH</given-names></name><name><surname>Ahmed</surname><given-names>RL</given-names></name><name><surname>Yee</surname><given-names>D</given-names></name></person-group><article-title>Effects of weight training on quality of life in recent breast cancer survivors: the weight training for breast cancer survivors (WTBS) study</article-title><source><italic>Cancer</italic></source><year>2006</year><volume>106</volume><issue>9</issue><fpage>2076</fpage><lpage>2083</lpage><pub-id pub-id-type="pmid">16568409</pub-id></element-citation></ref><ref id="B18"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delmonico</surname><given-names>MJ</given-names></name><name><surname>Kostek</surname><given-names>MC</given-names></name><name><surname>Doldo</surname><given-names>NA</given-names></name><etal></etal></person-group><article-title>Effects of moderate-velocity strength training on peak muscle power and movement velocity: do women respond differently than men?</article-title><source><italic>Journal of Applied Physiology</italic></source><year>2005</year><volume>99</volume><issue>5</issue><fpage>1712</fpage><lpage>1718</lpage><pub-id pub-id-type="pmid">16002767</pub-id></element-citation></ref><ref id="B37"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurley</surname><given-names>BF</given-names></name><name><surname>Redmond</surname><given-names>RA</given-names></name><name><surname>Pratley</surname><given-names>RE</given-names></name><name><surname>Treuth</surname><given-names>MS</given-names></name><name><surname>Rogers</surname><given-names>MA</given-names></name><name><surname>Goldberg</surname><given-names>AP</given-names></name></person-group><article-title>Effects of strength training on muscle hypertrophy and muscle cell disruption in elder men</article-title><source><italic>International Journal of Sports Medicine</italic></source><year>1995</year><volume>16</volume><issue>6</issue><fpage>378</fpage><lpage>384</lpage><pub-id pub-id-type="pmid">7591389</pub-id></element-citation></ref><ref id="B51"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemmer</surname><given-names>JT</given-names></name><name><surname>Hurlbut</surname><given-names>DE</given-names></name><name><surname>Martel</surname><given-names>GF</given-names></name><etal></etal></person-group><article-title>Age and gender responses to strength training and detraining</article-title><source><italic>Medicine and Science in Sports and Exercise</italic></source><year>2000</year><volume>32</volume><issue>8</issue><fpage>1505</fpage><lpage>1512</lpage><pub-id pub-id-type="pmid">10949019</pub-id></element-citation></ref><ref id="B23"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fielding</surname><given-names>RA</given-names></name><name><surname>LeBrasseur</surname><given-names>NK</given-names></name><name><surname>Cuoco</surname><given-names>A</given-names></name><name><surname>Bean</surname><given-names>J</given-names></name><name><surname>Mizer</surname><given-names>K</given-names></name><name><surname>Fiatarone Singh</surname><given-names>MA</given-names></name></person-group><article-title>High-velocity resistance training increases skeletal muscle peak power in older women</article-title><source><italic>Journal of the American Geriatrics Society</italic></source><year>2002</year><volume>50</volume><issue>4</issue><fpage>655</fpage><lpage>662</lpage><pub-id pub-id-type="pmid">11982665</pub-id></element-citation></ref><ref id="B71"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>AS</given-names></name><name><surname>Ivey</surname><given-names>FM</given-names></name><name><surname>Hurlbut</surname><given-names>DE</given-names></name><etal></etal></person-group><article-title>Regional bone mineral density after resistive training in young and older men and women</article-title><source><italic>Scandinavian Journal of Medicine and Science in Sports</italic></source><year>2004</year><volume>14</volume><issue>1</issue><fpage>16</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">14723783</pub-id></element-citation></ref><ref id="B81"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigal</surname><given-names>RJ</given-names></name><name><surname>Kenny</surname><given-names>GP</given-names></name><name><surname>Boulé</surname><given-names>NG</given-names></name><etal></etal></person-group><article-title>Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial</article-title><source><italic>Annals of Internal Medicine</italic></source><year>2007</year><volume>147</volume><issue>6</issue><fpage>357</fpage><lpage>369</lpage><pub-id pub-id-type="pmid">17876019</pub-id></element-citation></ref><ref id="B86"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smutok</surname><given-names>MA</given-names></name><name><surname>Reece</surname><given-names>C</given-names></name><name><surname>Kohhinos</surname><given-names>PF</given-names></name><etal></etal></person-group><article-title>Effects of exercise training modality on glucose tolerance in men with abnormal glucose regulation</article-title><source><italic>International Journal of Sports Medicine</italic></source><year>1994</year><volume>15</volume><issue>6</issue><fpage>283</fpage><lpage>289</lpage><pub-id pub-id-type="pmid">7822064</pub-id></element-citation></ref><ref id="B89"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treuth</surname><given-names>MS</given-names></name><name><surname>Ryan</surname><given-names>AS</given-names></name><name><surname>Pratley</surname><given-names>RE</given-names></name><etal></etal></person-group><article-title>Effects of strength training on total and regional body composition in older men</article-title><source><italic>Journal of Applied Physiology</italic></source><year>1994</year><volume>77</volume><issue>2</issue><fpage>614</fpage><lpage>620</lpage><pub-id pub-id-type="pmid">8002507</pub-id></element-citation></ref><ref id="B34"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henwood</surname><given-names>TR</given-names></name><name><surname>Taaffe</surname><given-names>DR</given-names></name></person-group><article-title>Improved physical performance in older adults undertaking a short-term programme of high-velocity resistance training</article-title><source><italic>Gerontology</italic></source><year>2005</year><volume>51</volume><issue>2</issue><fpage>108</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">15711077</pub-id></element-citation></ref><ref id="B90"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname><given-names>KR</given-names></name><name><surname>Braith</surname><given-names>RW</given-names></name><name><surname>Feldman</surname><given-names>RA</given-names></name><etal></etal></person-group><article-title>Resistance exercise and physical performance in adults aged 60 to 83</article-title><source><italic>Journal of the American Geriatrics Society</italic></source><year>2002</year><volume>50</volume><issue>6</issue><fpage>1100</fpage><lpage>1107</lpage><pub-id pub-id-type="pmid">12110072</pub-id></element-citation></ref><ref id="B49"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirk</surname><given-names>EP</given-names></name><name><surname>Donnelly</surname><given-names>JE</given-names></name><name><surname>Smith</surname><given-names>BK</given-names></name><etal></etal></person-group><article-title>Minimal resistance training improves daily energy expenditure and fat oxidation</article-title><source><italic>Medicine and Science in Sports and Exercise</italic></source><year>2009</year><volume>41</volume><issue>5</issue><fpage>1122</fpage><lpage>1129</lpage><pub-id pub-id-type="pmid">19346974</pub-id></element-citation></ref><ref id="B52"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemmer</surname><given-names>JT</given-names></name><name><surname>Ivey</surname><given-names>FM</given-names></name><name><surname>Ryan</surname><given-names>AS</given-names></name><etal></etal></person-group><article-title>Effect of strength training on resting metabolic rate and physical activity: age and gender comparisons</article-title><source><italic>Medicine and Science in Sports and Exercise</italic></source><year>2001</year><volume>33</volume><issue>4</issue><fpage>532</fpage><lpage>541</lpage><pub-id pub-id-type="pmid">11283427</pub-id></element-citation></ref><ref id="B70"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz</surname><given-names>JR</given-names></name><name><surname>Sui</surname><given-names>X</given-names></name><name><surname>Lobelo</surname><given-names>F</given-names></name><etal></etal></person-group><article-title>Muscular strength and adiposity as predictors of adulthood cancer mortality in men</article-title><source><italic>Cancer Epidemiology Biomarkers and Prevention</italic></source><year>2009</year><volume>18</volume><issue>5</issue><fpage>1468</fpage><lpage>1476</lpage></element-citation></ref><ref id="B24"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freedman</surname><given-names>RJ</given-names></name><name><surname>Aziz</surname><given-names>N</given-names></name><name><surname>Albanes</surname><given-names>D</given-names></name><etal></etal></person-group><article-title>Weight and Body Composition Changes during and after Adjuvant Chemotherapy in Women with Breast Cancer</article-title><source><italic>Journal of Clinical Endocrinology and Metabolism</italic></source><year>2004</year><volume>89</volume><issue>5</issue><fpage>2248</fpage><lpage>2253</lpage><pub-id pub-id-type="pmid">15126549</pub-id></element-citation></ref><ref id="B6"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battaglini</surname><given-names>C</given-names></name><name><surname>Bottaro</surname><given-names>M</given-names></name><name><surname>Dennehy</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>The effects of an individualized exercise intervention on body composition in breast cancer patients undergoing treatment</article-title><source><italic>Sao Paulo Medical Journal</italic></source><year>2007</year><volume>125</volume><issue>1</issue><fpage>22</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">17505681</pub-id></element-citation></ref><ref id="B15"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Courneya</surname><given-names>KS</given-names></name><name><surname>Segal</surname><given-names>RJ</given-names></name><name><surname>Mackey</surname><given-names>JR</given-names></name><etal></etal></person-group><article-title>Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial</article-title><source><italic>Journal of Clinical Oncology</italic></source><year>2007</year><volume>25</volume><issue>28</issue><fpage>4396</fpage><lpage>4404</lpage><pub-id pub-id-type="pmid">17785708</pub-id></element-citation></ref><ref id="B77"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>AL</given-names></name><name><surname>Winters-Stone</surname><given-names>K</given-names></name><name><surname>Gallucci</surname><given-names>B</given-names></name></person-group><article-title>Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy</article-title><source><italic>Oncology Nursing Forum</italic></source><year>2007</year><volume>34</volume><issue>3</issue><fpage>627</fpage><lpage>633</lpage><pub-id pub-id-type="pmid">17573321</pub-id></element-citation></ref><ref id="B9"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhasin</surname><given-names>S</given-names></name><name><surname>Woodhouse</surname><given-names>L</given-names></name><name><surname>Storer</surname><given-names>TW</given-names></name></person-group><article-title>Proof of the effect of testosterone on skeletal muscle</article-title><source><italic>Journal of Endocrinology</italic></source><year>2001</year><volume>170</volume><issue>1</issue><fpage>27</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">11431134</pub-id></element-citation></ref><ref id="B78"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segal</surname><given-names>RJ</given-names></name><name><surname>Reid</surname><given-names>RD</given-names></name><name><surname>Courneya</surname><given-names>KS</given-names></name><etal></etal></person-group><article-title>Resistance exercise in men receiving androgen deprivation therapy for prostate cancer</article-title><source><italic>Journal of Clinical Oncology</italic></source><year>2003</year><volume>21</volume><issue>9</issue><fpage>1653</fpage><lpage>1659</lpage><pub-id pub-id-type="pmid">12721238</pub-id></element-citation></ref><ref id="B79"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segal</surname><given-names>RJ</given-names></name><name><surname>Reid</surname><given-names>RD</given-names></name><name><surname>Courneya</surname><given-names>KS</given-names></name><etal></etal></person-group><article-title>Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer</article-title><source><italic>Journal of Clinical Oncology</italic></source><year>2009</year><volume>27</volume><issue>3</issue><fpage>344</fpage><lpage>351</lpage><pub-id pub-id-type="pmid">19064985</pub-id></element-citation></ref><ref id="B25"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galvão</surname><given-names>DA</given-names></name><name><surname>Nosaka</surname><given-names>K</given-names></name><name><surname>Taaffe</surname><given-names>DR</given-names></name><etal></etal></person-group><article-title>Resistance training and reduction of treatment side effects in prostate cancer</article-title><source><italic>Medicine and Science in Sports and Exercise</italic></source><year>2006</year><volume>38</volume><issue>12</issue><fpage>2045</fpage><lpage>2052</lpage><pub-id pub-id-type="pmid">17146309</pub-id></element-citation></ref><ref id="B32"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>PA</given-names></name><name><surname>Dechet</surname><given-names>CB</given-names></name><name><surname>Porucznik</surname><given-names>CA</given-names></name><name><surname>LaStayo</surname><given-names>PC</given-names></name></person-group><article-title>Comparing eccentric resistance exercise in prostate cancer survivors on and off hormone therapy: a pilot study</article-title><source><italic>PM and R</italic></source><year>2009</year><volume>1</volume><issue>11</issue><fpage>1019</fpage><lpage>1024</lpage></element-citation></ref><ref id="B1"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>RL</given-names></name><name><surname>Thomas</surname><given-names>W</given-names></name><name><surname>Yee</surname><given-names>D</given-names></name><name><surname>Schmitz</surname><given-names>KH</given-names></name></person-group><article-title>Randomized controlled trial of weight training and lymphedema in breast cancer survivors</article-title><source><italic>Journal of Clinical Oncology</italic></source><year>2006</year><volume>24</volume><issue>18</issue><fpage>2765</fpage><lpage>2772</lpage><pub-id pub-id-type="pmid">16702582</pub-id></element-citation></ref><ref id="B35"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herman</surname><given-names>S</given-names></name><name><surname>Kiely</surname><given-names>DK</given-names></name><name><surname>Leveille</surname><given-names>S</given-names></name><name><surname>O’Neill</surname><given-names>E</given-names></name><name><surname>Cyberey</surname><given-names>S</given-names></name><name><surname>Bean</surname><given-names>JF</given-names></name></person-group><article-title>Upper and lower limb muscle power relationships in mobility-limited older adults</article-title><source><italic>Journals of Gerontology A</italic></source><year>2005</year><volume>60</volume><issue>4</issue><fpage>476</fpage><lpage>480</lpage></element-citation></ref><ref id="B7"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bean</surname><given-names>JF</given-names></name><name><surname>Kiely</surname><given-names>DK</given-names></name><name><surname>Herman</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>The relationship between leg power and physical performance in mobility-limited older people</article-title><source><italic>Journal of the American Geriatrics Society</italic></source><year>2002</year><volume>50</volume><issue>3</issue><fpage>461</fpage><lpage>467</lpage><pub-id pub-id-type="pmid">11943041</pub-id></element-citation></ref><ref id="B8"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bean</surname><given-names>JF</given-names></name><name><surname>Leveille</surname><given-names>SG</given-names></name><name><surname>Kiely</surname><given-names>DK</given-names></name><name><surname>Bandinelli</surname><given-names>S</given-names></name><name><surname>Guralnik</surname><given-names>JM</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name></person-group><article-title>A comparison of leg power and leg strength within the inCHIANTI study: which influences mobility more?</article-title><source><italic>Journals of Gerontology A</italic></source><year>2003</year><volume>58</volume><issue>8</issue><fpage>728</fpage><lpage>733</lpage></element-citation></ref><ref id="B59"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metter</surname><given-names>EJ</given-names></name><name><surname>Conwit</surname><given-names>R</given-names></name><name><surname>Tobin</surname><given-names>J</given-names></name><name><surname>Fozard</surname><given-names>JL</given-names></name></person-group><article-title>Age-associated loss of power and strength in the upper extremities in women and men</article-title><source><italic>Journals of Gerontology A</italic></source><year>1997</year><volume>52</volume><issue>5</issue><fpage>B267</fpage><lpage>B276</lpage></element-citation></ref><ref id="B47"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jozsi</surname><given-names>AC</given-names></name><name><surname>Campbell</surname><given-names>WW</given-names></name><name><surname>Joseph</surname><given-names>L</given-names></name><name><surname>Davey</surname><given-names>SL</given-names></name><name><surname>Evans</surname><given-names>WJ</given-names></name></person-group><article-title>Changes in power with resistance training in older and younger men and women</article-title><source><italic>Journals of Gerontology A</italic></source><year>1999</year><volume>54</volume><issue>11</issue><fpage>M591</fpage><lpage>M596</lpage></element-citation></ref><ref id="B56"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lønning</surname><given-names>PE</given-names></name><name><surname>Geisler</surname><given-names>J</given-names></name><name><surname>Krag</surname><given-names>LE</given-names></name><etal></etal></person-group><article-title>Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer</article-title><source><italic>Journal of Clinical Oncology</italic></source><year>2005</year><volume>23</volume><issue>22</issue><fpage>5126</fpage><lpage>5137</lpage><pub-id pub-id-type="pmid">15983390</pub-id></element-citation></ref><ref id="B68"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>DM</given-names></name><name><surname>Doughty</surname><given-names>J</given-names></name><name><surname>Eastell</surname><given-names>R</given-names></name><etal></etal></person-group><article-title>Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group</article-title><source><italic>Cancer Treatment Reviews</italic></source><year>2008</year><volume>34</volume><issue>supplement 1</issue><fpage>S3</fpage><lpage>S18</lpage><pub-id pub-id-type="pmid">18515009</pub-id></element-citation></ref><ref id="B65"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newton</surname><given-names>RU</given-names></name><name><surname>Taaffe</surname><given-names>DR</given-names></name><name><surname>Spry</surname><given-names>N</given-names></name><etal></etal></person-group><article-title>A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer</article-title><source><italic>BMC Cancer</italic></source><year>2009</year><volume>9, article 210</volume></element-citation></ref><ref id="B55"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lohman</surname><given-names>T</given-names></name><name><surname>Going</surname><given-names>S</given-names></name><name><surname>Pamenter</surname><given-names>R</given-names></name><etal></etal></person-group><article-title>Effects of resistance training on regional and total bone mineral density in premenopausal women: a randomized prospective study</article-title><source><italic>Journal of Bone and Mineral Research</italic></source><year>1995</year><volume>10</volume><issue>7</issue><fpage>1015</fpage><lpage>1024</lpage><pub-id pub-id-type="pmid">7484276</pub-id></element-citation></ref><ref id="B58"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menkes</surname><given-names>A</given-names></name><name><surname>Mazel</surname><given-names>S</given-names></name><name><surname>Redmond</surname><given-names>RA</given-names></name><etal></etal></person-group><article-title>Strength training increases regional bone mineral density and bone remodeling in middle-aged and older men</article-title><source><italic>Journal of Applied Physiology</italic></source><year>1993</year><volume>74</volume><issue>5</issue><fpage>2478</fpage><lpage>2484</lpage><pub-id pub-id-type="pmid">8335581</pub-id></element-citation></ref><ref id="B63"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>ME</given-names></name><name><surname>Fiatarone</surname><given-names>MA</given-names></name><name><surname>Morganti</surname><given-names>CM</given-names></name><name><surname>Trice</surname><given-names>I</given-names></name><name><surname>Greenberg</surname><given-names>RA</given-names></name><name><surname>Evans</surname><given-names>WJ</given-names></name></person-group><article-title>Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures: a randomized controlled trial</article-title><source><italic>Journal of the American Medical Association</italic></source><year>1994</year><volume>272</volume><issue>24</issue><fpage>1909</fpage><lpage>1914</lpage><pub-id pub-id-type="pmid">7990242</pub-id></element-citation></ref><ref id="B16"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Courtney</surname><given-names>AC</given-names></name><name><surname>Wachtel</surname><given-names>EF</given-names></name><name><surname>Myers</surname><given-names>ER</given-names></name><name><surname>Hayes</surname><given-names>WC</given-names></name></person-group><article-title>Effects of loading rate on strength of the proximal femur</article-title><source><italic>Calcified Tissue International</italic></source><year>1994</year><volume>55</volume><issue>1</issue><fpage>53</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">7922790</pub-id></element-citation></ref><ref id="B2"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basaria</surname><given-names>S</given-names></name></person-group><article-title>Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth</article-title><source><italic>Journal of Andrology</italic></source><year>2008</year><volume>29</volume><issue>5</issue><fpage>534</fpage><lpage>539</lpage><pub-id pub-id-type="pmid">18567642</pub-id></element-citation></ref><ref id="B42"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janssen</surname><given-names>I</given-names></name><name><surname>Ross</surname><given-names>R</given-names></name></person-group><article-title>Linking age-related changes in skeletal muscle mass and composition with metabolism and disease</article-title><source><italic>Journal of Nutrition, Health and Aging</italic></source><year>2005</year><volume>9</volume><issue>6</issue><fpage>408</fpage><lpage>419</lpage></element-citation></ref><ref id="B30"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodpaster</surname><given-names>BH</given-names></name><name><surname>Thaete</surname><given-names>FL</given-names></name><name><surname>Kelley</surname><given-names>DE</given-names></name></person-group><article-title>Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus</article-title><source><italic>American Journal of Clinical Nutrition</italic></source><year>2000</year><volume>71</volume><issue>4</issue><fpage>885</fpage><lpage>892</lpage><pub-id pub-id-type="pmid">10731493</pub-id></element-citation></ref><ref id="B29"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodpaster</surname><given-names>BH</given-names></name><name><surname>Carlson</surname><given-names>CL</given-names></name><name><surname>Visser</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Attenuation of skeletal muscle and strength in the elderly: the health ABC study</article-title><source><italic>Journal of Applied Physiology</italic></source><year>2001</year><volume>90</volume><issue>6</issue><fpage>2157</fpage><lpage>2165</lpage><pub-id pub-id-type="pmid">11356778</pub-id></element-citation></ref><ref id="B92"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visser</surname><given-names>M</given-names></name><name><surname>Kritchevsky</surname><given-names>SB</given-names></name><name><surname>Goodpaster</surname><given-names>BH</given-names></name><etal></etal></person-group><article-title>Leg muscle mass and composition in relation to lower extremity performance in men and women aged 70 to 79: the Health, Aging and Body Composition Study</article-title><source><italic>Journal of the American Geriatrics Society</italic></source><year>2002</year><volume>50</volume><issue>5</issue><fpage>897</fpage><lpage>904</lpage><pub-id pub-id-type="pmid">12028178</pub-id></element-citation></ref><ref id="B91"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visser</surname><given-names>M</given-names></name><name><surname>Goodpaster</surname><given-names>BH</given-names></name><name><surname>Kritchevsky</surname><given-names>SB</given-names></name><etal></etal></person-group><article-title>Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons</article-title><source><italic>Journals of Gerontology A</italic></source><year>2005</year><volume>60</volume><issue>3</issue><fpage>324</fpage><lpage>333</lpage></element-citation></ref><ref id="B54"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ligibel</surname><given-names>JA</given-names></name><name><surname>Campbell</surname><given-names>N</given-names></name><name><surname>Partridge</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors</article-title><source><italic>Journal of Clinical Oncology</italic></source><year>2008</year><volume>26</volume><issue>6</issue><fpage>907</fpage><lpage>912</lpage><pub-id pub-id-type="pmid">18281663</pub-id></element-citation></ref><ref id="B48"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kintzel</surname><given-names>PE</given-names></name><name><surname>Chase</surname><given-names>SL</given-names></name><name><surname>Schultz</surname><given-names>LM</given-names></name><name><surname>O’Rourke</surname><given-names>TJ</given-names></name></person-group><article-title>Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer</article-title><source><italic>Pharmacotherapy</italic></source><year>2008</year><volume>28</volume><issue>12</issue><fpage>1511</fpage><lpage>1522</lpage><pub-id pub-id-type="pmid">19025432</pub-id></element-citation></ref><ref id="B33"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Healy</surname><given-names>LA</given-names></name><name><surname>Ryan</surname><given-names>AM</given-names></name><name><surname>Carroll</surname><given-names>P</given-names></name><etal></etal></person-group><article-title>Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer</article-title><source><italic>Clinical Oncology</italic></source><year>2010</year><volume>22</volume><issue>4</issue><fpage>281</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">20189371</pub-id></element-citation></ref><ref id="B27"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galvão</surname><given-names>DA</given-names></name><name><surname>Taaffe</surname><given-names>DR</given-names></name><name><surname>Spry</surname><given-names>N</given-names></name><name><surname>Joseph</surname><given-names>D</given-names></name><name><surname>Newton</surname><given-names>RU</given-names></name></person-group><article-title>Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial</article-title><source><italic>Journal of Clinical Oncology</italic></source><year>2010</year><volume>28</volume><issue>2</issue><fpage>340</fpage><lpage>347</lpage><pub-id pub-id-type="pmid">19949016</pub-id></element-citation></ref><ref id="B39"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibañez</surname><given-names>J</given-names></name><name><surname>Izquierdo</surname><given-names>M</given-names></name><name><surname>Argüelles</surname><given-names>I</given-names></name><etal></etal></person-group><article-title>Twice-weekly progressive resistance training decreases abdominal fat and improves insulin sensitivity in older men with type 2 diabetes</article-title><source><italic>Diabetes Care</italic></source><year>2005</year><volume>28</volume><issue>3</issue><fpage>662</fpage><lpage>667</lpage><pub-id pub-id-type="pmid">15735205</pub-id></element-citation></ref><ref id="B60"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>JP</given-names></name><name><surname>Pratley</surname><given-names>RE</given-names></name><name><surname>Goldberg</surname><given-names>AP</given-names></name><etal></etal></person-group><article-title>Strength training increases insulin action in healthy 50- to 65-yr-old men</article-title><source><italic>Journal of Applied Physiology</italic></source><year>1994</year><volume>77</volume><issue>3</issue><fpage>1122</fpage><lpage>1127</lpage><pub-id pub-id-type="pmid">7836113</pub-id></element-citation></ref><ref id="B72"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>AS</given-names></name><name><surname>Pratley</surname><given-names>RE</given-names></name><name><surname>Goldberg</surname><given-names>AP</given-names></name><name><surname>Elahi</surname><given-names>D</given-names></name></person-group><article-title>Resistive training increases insulin action in postmenopausal women</article-title><source><italic>Journals of Gerontology A</italic></source><year>1996</year><volume>51</volume><issue>5</issue><fpage>M199</fpage><lpage>M205</lpage></element-citation></ref><ref id="B87"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tchen</surname><given-names>N</given-names></name><name><surname>Juffs</surname><given-names>HG</given-names></name><name><surname>Downie</surname><given-names>FP</given-names></name><etal></etal></person-group><article-title>Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer</article-title><source><italic>Journal of Clinical Oncology</italic></source><year>2003</year><volume>21</volume><issue>22</issue><fpage>4175</fpage><lpage>4183</lpage><pub-id pub-id-type="pmid">14615445</pub-id></element-citation></ref><ref id="B40"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irwin</surname><given-names>ML</given-names></name><name><surname>Crumley</surname><given-names>D</given-names></name><name><surname>McTiernan</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study</article-title><source><italic>Cancer</italic></source><year>2003</year><volume>97</volume><fpage>1746</fpage><lpage>1757</lpage><pub-id pub-id-type="pmid">12655532</pub-id></element-citation></ref><ref id="B5"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battaglini</surname><given-names>CL</given-names></name><name><surname>Hackney</surname><given-names>AC</given-names></name><name><surname>Garcia</surname><given-names>R</given-names></name><name><surname>Groff</surname><given-names>D</given-names></name><name><surname>Evans</surname><given-names>E</given-names></name><name><surname>Shea</surname><given-names>T</given-names></name></person-group><article-title>The effects of an exercise program in leukemia patients</article-title><source><italic>Sao Paulo Medical Journal</italic></source><year>2009</year><volume>125</volume><fpage>22</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">17505681</pub-id></element-citation></ref><ref id="B62"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mustian</surname><given-names>KM</given-names></name><name><surname>Peppone</surname><given-names>L</given-names></name><name><surname>Darling</surname><given-names>TV</given-names></name><name><surname>Palesh</surname><given-names>O</given-names></name><name><surname>Heckler</surname><given-names>CE</given-names></name><name><surname>Morrow</surname><given-names>GR</given-names></name></person-group><article-title>A 4-week home-based aerobic and resistance exercise program during radiation therapy: a pilot randomized clinical trial</article-title><source><italic>Journal of Supportive Oncology</italic></source><year>2009</year><volume>7</volume><issue>5</issue><fpage>158</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">19831159</pub-id></element-citation></ref><ref id="B75"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitz</surname><given-names>KH</given-names></name><name><surname>Ahmed</surname><given-names>RL</given-names></name><name><surname>Troxel</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Weight lifting in women with breast-cancer-related lymphedema</article-title><source><italic>New England Journal of Medicine</italic></source><year>2009</year><volume>361</volume><issue>7</issue><fpage>664</fpage><lpage>673</lpage><pub-id pub-id-type="pmid">19675330</pub-id></element-citation></ref></ref-list></back></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004A95 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 004A95 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:3034975
|texte= Intervening on the Side Effects of Hormone-Dependent Cancer Treatment: The Role of Strength Training
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:21318049" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |